Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E25.28 EPS (ttm)1.34 Insider Own0.50% Shs Outstand2.53B Perf Week-0.15%
Market Cap85.53B Forward P/E17.16 EPS next Y1.97 Insider Trans0.00% Shs Float2.50B Perf Month9.69%
Income3.39B PEG3.46 EPS next Q0.40 Inst Own14.80% Short Float1.12% Perf Quarter15.25%
Sales22.29B P/S3.84 EPS this Y23.80% Inst Trans11.60% Short Ratio6.45 Perf Half Y28.37%
Book/sh5.13 P/B6.60 EPS next Y6.08% ROA5.40% Target Price34.12 Perf Year13.02%
Cash/sh1.45 P/C23.37 EPS next 5Y7.30% ROE24.90% 52W Range25.55 - 35.04 Perf YTD23.90%
Dividend1.90 P/FCF- EPS past 5Y-17.60% ROI15.00% 52W High-3.40% Beta0.79
Dividend %5.61% Quick Ratio0.60 Sales past 5Y-7.30% Gross Margin82.70% 52W Low32.49% ATR0.48
Employees59700 Current Ratio0.80 Sales Q/Q-11.60% Oper. Margin21.40% RSI (14)65.76 Volatility0.93% 1.16%
OptionableYes Debt/Eq1.34 EPS Q/Q-16.90% Profit Margin15.20% Rel Volume0.59 Prev Close34.34
ShortableYes LT Debt/Eq1.12 EarningsApr 27 BMO Payout102.70% Avg Volume4.33M Price33.85
Recom2.00 SMA204.56% SMA508.11% SMA20012.43% Volume2,551,129 Change-1.43%
May-12-17Upgrade Credit Suisse Underperform → Neutral
Apr-10-17Downgrade Jefferies Buy → Hold
Apr-05-17Downgrade UBS Buy → Neutral
Mar-09-17Initiated Liberum Buy
Dec-09-16Upgrade Leerink Partners Mkt Perform → Outperform
Nov-25-16Upgrade Liberum Hold → Buy
Sep-23-16Initiated Piper Jaffray Overweight
Sep-12-16Upgrade Jefferies Hold → Buy
Aug-29-16Upgrade Argus Hold → Buy
Jul-12-16Initiated Argus Hold
Apr-12-16Downgrade Goldman Neutral → Sell
Mar-15-16Downgrade Jefferies Buy → Hold
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-08-16Downgrade HSBC Securities Buy → Hold
Jan-19-16Upgrade Barclays Underweight → Equal Weight
Dec-01-15Upgrade Morgan Stanley Underweight → Overweight
Nov-02-15Downgrade Nordea Buy → Hold
Oct-20-15Downgrade Credit Suisse Neutral → Underperform
Sep-18-15Upgrade Bryan Garnier Neutral → Buy
Jul-31-15Upgrade Swedbank Neutral → Buy
May-28-17 02:15PM  AstraZeneca recalls physician sample bottles of heart drug American City Business Journals
11:03AM  3 Top Dividend Stocks in Cancer Drugs Motley Fool
May-26-17 08:43AM  AstraZeneca Delivers New Data on Expanding Portfolio of Cancer Medicines at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting Business Wire
May-25-17 05:30PM  AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot Business Wire
May-24-17 10:36AM  Performance of Mercks Diabetes Portfolio in 1Q17 Market Realist
10:28AM  AstraZeneca's Bydureon Fails to Reduce Cardiovascular Risk Zacks
09:30AM  The Zacks Analyst Blog Highlights: Oracle, Chubb, AstraZeneca, Estee Lauder and Aflac Zacks
May-23-17 04:21PM  Novo Nordisk Diabetes Lead Unscathed Following AstraZeneca Trial Investor's Business Daily
04:05PM  New Research Reports for Oracle, Chubb, AstraZeneca & Others Zacks
03:02PM  Biotech And Pharma Industry And Stock News Investor's Business Daily
10:33AM  AstraZeneca Sells Marketing Rights to Seloken in Europe Zacks
08:31AM  AstraZeneca PLC (AZN): Strong Industry, Solid Earnings Estimate Revisions Zacks
07:05AM  BYDUREON EXSCEL Trial Meets Primary Safety Objective in Type-2 Diabetes Patients at Wide Range of Cardiovascular Risk Business Wire
04:14AM  AstraZeneca Shares Rise as Investors Shrug Off Mixed Diabetes Results TheStreet.com
May-22-17 04:46PM  Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab Zacks
02:35PM  Phase III ZONDA Trial for benralizumab Shows Ability to Reduce Oral Steroid Use in Severe Asthma Patients Business Wire
02:30PM  Severe asthma drug shows AstraZeneca promise beyond cancer Reuters
11:26AM  [$$] AstraZeneca sells Seloken European rights for $300m Financial Times
03:01AM  AstraZeneca sells ageing beta-blocker to Recordati for $300 mln Reuters
May-18-17 12:43PM  Build Your Investing Watch List With Stock Ratings, Buy Zones, Earnings Investor's Business Daily
12:42PM  Which Stocks Are Showing Rising Relative Strength? Investor's Business Daily
11:42AM  Big Pharma Stock Astrazeneca Gets Relative Strength Upgrade Investor's Business Daily
08:00AM  Vertex Pharmaceuticals' Shares Pop in Afterhours Trading After FDA Approval while AstraZeneca Sinks on Clovis Upgrade Accesswire
May-17-17 05:05PM  Did AstraZeneca Rival Just Launch A Potential Blockbuster Drug? Investor's Business Daily
12:39PM  Eli Lilly: Worries Ahead In Patent Fight Barrons.com
May-16-17 05:42PM  [$$] Big pharma hopes rule change will ease China sales pain Financial Times
May-15-17 04:19PM  AstraZeneca Has Opportunity In Lung Cancer Treatment Vs. Dow's Merck Investor's Business Daily
10:28AM  AstraZeneca Imfinzi Positive in Phase III Lung Cancer Study Zacks
08:20AM  AstraZeneca (AZN) Shows Strength: Stock Moves 9.2% Higher Zacks
08:00AM  AstraZeneca Soars After Positive Phase 3 Trial While Traders Get Confident Again With Geron Accesswire
07:46AM  How AstraZeneca cancer drug forecasts are set to rise Reuters
May-12-17 04:39PM  Why AstraZeneca, Globalstar, and Snap Jumped Today Motley Fool +9.22%
04:06PM  AstraZeneca Shares Jump On Cancer Trial That Rivals Dow's Merck Investor's Business Daily
02:51PM  [$$] Forterra and Ibstock hit records on UK housing hopes Financial Times
01:20PM  Is AstraZeneca The Next Big Player In Cancer Immunotherapies? Barrons.com
12:46PM  Solid Pipeline Offsets Competition for AstraZeneca Morningstar
12:19PM  FTSE 100 closes at an all-time high as AstraZeneca rallies, pound stalls MarketWatch
10:50AM  AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What's Next Forbes
10:31AM  Sprint, T-Mobile jump on merger talk, Fiat Chrysler announces major recall, Tiffany gets upgraded Yahoo Finance
10:26AM  Sprint, T-Mobile jump on merger talk, Fiat Chrysler announces major recall, Tiffany gets upgraded Yahoo Finance Video
09:20AM  JC Penney results give investors more reasons to run from retail; US strikes trade deal with China Yahoo Finance
08:04AM  [$$] AstraZeneca boosted by positive lung cancer drug trial Financial Times
07:20AM  Yahoo Finance Live: Market Movers - May 12th, 2017 Yahoo Finance Video
06:57AM  5 Things You Must Know Before the Market Opens Friday TheStreet.com
06:23AM  Key AstraZeneca drug shown to reduce risk of death from lung cancer Reuters
03:55AM  AstraZeneca Shares Hit 2017 High After Phase-3 Trial Success for Lung Cancer Treatment TheStreet.com
02:27AM  AstraZeneca's durvalumab shown in trial to reduce risk of death from lung cancer Reuters
May-11-17 04:34PM  Can Dow's Merck Hang On To Edge In Lung Cancer Treatment? Investor's Business Daily
May-10-17 04:18PM  Tesaro Gets A Jump In Ovarian Cancer As Rivalries Heat Up Investor's Business Daily
05:50AM  Roche's Loss In Bladder Cancer Lifts Astrazeneca and Could Boost Bristol-Myers TheStreet.com
03:36AM  AstraZeneca asthma drug fails, after similar setback at Roche Reuters
02:37AM  AstraZeneca's asthma drug fails in study Reuters
May-08-17 08:46AM  Pharma Stock Roundup: Merck, Pfizer Report Q1 Earnings, J&J Talc Powder Lawsuit Zacks
May-04-17 04:48PM  How Clovis Might Still Quash AstraZeneca, Tesaro In Cancer Investor's Business Daily
01:29PM  Biotech Stock Mailbag: Why Clovis Oncology Is Trading Lower on Rubraca Study Update TheStreet.com
08:15AM  Blog Coverage: Pieris Announces Collaboration with AstraZeneca Accesswire
May-03-17 10:14AM  Company News for May 03, 2017 Zacks
10:05AM  Boston-based Pieris adds AstraZeneca as R&D partner in $45M deal American City Business Journals
08:14AM  Pieris Pharma stock soars 54% on news of $57.5 mln AstraZeneca deal MarketWatch
03:10AM  AstraZeneca boosts early respiratory medicine with Pieris deal Reuters
May-02-17 11:38AM  [$$] AstraZeneca wins US approval for 'cornerstone' cancer drug Financial Times
04:18AM  Astrazeneca Shares Gain After FDA Approves 'Durvalumab' Bladder Cancer Treatment TheStreet.com
03:21AM  AstraZeneca immunotherapy wins first approval in bladder cancer Reuters
May-01-17 06:23PM  FDA OKs immune-boosting drug for advanced bladder cancer Associated Press
03:48PM  AstraZeneca immunotherapy wins first approval in bladder cancer Reuters
03:39PM  ETFs with exposure to AstraZeneca Plc : May 1, 2017 Capital Cube
02:23PM  AstraZenecas IMFINZI (durvalumab) Receives US FDA Accelerated Approval for Previously Treated Patients with Advanced Bladder Cancer Business Wire
02:20PM  AstraZeneca's Imfinzi (durvalumab) Receives US FDA Accelerated Approval for Previously Treated Patients With Advanced Bladder Cancer Marketwired
01:40PM  U.S. FDA approves AstraZeneca's immunotherapy for bladder cancer Reuters
01:06PM  U.S. FDA approves AstraZeneca's bladder cancer drug Reuters
Apr-28-17 04:09PM  Vertex Big Winner In Biopharma Q1 As AbbVie, AstraZeneca Dip Investor's Business Daily
12:01PM  [$$] Biotech and big pharma reap rewards from partnerships Financial Times
11:14AM  AstraZeneca Plc :AZN-US: Earnings Analysis: Q1, 2017 By the Numbers : April 28, 2017 Capital Cube
10:31AM  AstraZeneca (AZN) Q1 Earnings Beat, Revenues Meet Estimates Zacks
Apr-27-17 05:03PM  AstraZeneca Wallops Profit Views Despite Toppling Sales; Eyes Key Trial Investor's Business Daily
04:43PM  Celgene Dips On $95 Million Lag In Psoriasis Sales, But Earnings Top Investor's Business Daily
03:12PM  [$$] AstraZeneca Shareholders Rebel Against Executive-Award Changes The Wall Street Journal
01:37PM  [$$] AstraZeneca suffers shareholder rebellion on pay Financial Times
12:55PM  Drug Trials Heating Up In The Breast and Ovarian Cancer Treatment Space Benzinga
12:00PM  FTSE 100 sees first loss in 4 days, but Lloyds climbs after earnings MarketWatch
08:35AM  AstraZeneca Shareholders Revolt Against Drug Giant's Pay Report Bloomberg
07:04AM  AstraZeneca aims to escape drug sales trough in second half Reuters
06:48AM  [$$] AstraZeneca Profit Drops on Decline in Blockbuster-Drug Revenue The Wall Street Journal
05:04AM  AstraZeneca committed to UK, despite market challenges Reuters
05:00AM  Astrazeneca beats 1Q profit forecasts Associated Press
03:49AM  AstraZeneca Tops Earnings Estimate, but Crestor and Onglyza Sales Slow TheStreet.com
03:07AM  AstraZeneca Q1 upbeat on cancer drugs despite Q1 sales drop Associated Press
02:14AM  AstraZeneca sales fall further as generic competition bites deep Reuters
Apr-26-17 12:05PM  What Analysts Recommend for AstraZeneca Market Realist
10:38AM  Why AstraZeneca Could See Lower Revenues in 1Q17 Market Realist
08:38AM  What Analysts Predict for AstraZenecas 1Q17 Earnings Market Realist
06:11AM  AstraZeneca third-line lung cancer trial delayed by few months Reuters
Apr-25-17 03:43PM  Tesaro Inc Bulls Need a Reality Check Motley Fool
09:00AM  AstraZeneca moving costs rise as new HQ nears completion Reuters
Apr-21-17 06:52AM  Tesaros Zejula Flops as H&S Pattern Emerges Investopedia
05:44AM  What to Expect From European Pharmaceuticals' First Quarter Results TheStreet.com
Apr-20-17 01:21PM  AbbVie's PARP Inhibitor Comes Up Empty Motley Fool
09:52AM  Group launching website to brand region as biotech leader American City Business Journals
Apr-18-17 07:27AM  [$$] Circassia halts allergy programme after failed trials Financial Times
Apr-10-17 04:25PM  Could Dow Stock Merck Undercut AstraZeneca In Lung Cancer? Investor's Business Daily
AstraZeneca PLC engages in the discovery, development, manufacture, and commercialization of prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases worldwide. Its marketed products comprise Arimidex, Casodex/Cosudex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Imdur, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalent and Synagis for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, Vimovo1, and Zomig for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. It serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 132 projects, of which 120 are in the clinical phase of development. It has collaboration agreements with Valeant Holdings Ireland, and Eli Lilly and Company; definitive agreement with Foundation Medicine, Inc.; strategic collaboration with FibroGen, Astellas, and Pieris Pharmaceuticals Inc; collaboration and license agreement with Celgene International Sarl; and license agreement with LEO Pharma A/S. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
EBAY eBay Inc. daily Stock Chart
EBAY [NASD]
eBay Inc.
IndexS&P 500 P/E4.98 EPS (ttm)7.01 Insider Own6.60% Shs Outstand1.09B Perf Week3.16%
Market Cap38.12B Forward P/E15.83 EPS next Y2.21 Insider Trans-0.62% Shs Float1.01B Perf Month5.57%
Income7.84B PEG0.70 EPS next Q0.45 Inst Own87.00% Short Float1.94% Perf Quarter1.81%
Sales9.06B P/S4.21 EPS this Y299.00% Inst Trans0.36% Short Ratio2.30 Perf Half Y20.76%
Book/sh10.71 P/B3.26 EPS next Y9.81% ROA35.10% Target Price35.54 Perf Year44.69%
Cash/sh6.17 P/C5.66 EPS next 5Y7.09% ROE88.30% 52W Range22.30 - 35.30 Perf YTD17.55%
Dividend- P/FCF17.62 EPS past 5Y21.00% ROI30.60% 52W High-1.13% Beta1.37
Dividend %- Quick Ratio1.90 Sales past 5Y-5.10% Gross Margin77.40% 52W Low56.50% ATR0.62
Employees12600 Current Ratio1.90 Sales Q/Q3.70% Oper. Margin24.90% RSI (14)61.15 Volatility1.50% 1.59%
OptionableYes Debt/Eq0.77 EPS Q/Q128.00% Profit Margin86.30% Rel Volume0.78 Prev Close35.22
ShortableYes LT Debt/Eq0.58 EarningsApr 19 AMC Payout0.00% Avg Volume8.51M Price34.90
Recom2.50 SMA202.92% SMA503.58% SMA20010.27% Volume6,616,781 Change-0.91%
Apr-20-17Reiterated Canaccord Genuity Hold $31 → $32
Apr-20-17Downgrade Monness Crespi & Hardt Buy → Neutral
Apr-13-17Reiterated Aegis Capital Buy $38 → $40
Mar-29-17Initiated Barclays Overweight $41
Mar-29-17Initiated Barclays Overweight
Feb-17-17Resumed Pacific Crest Sector Weight
Jan-26-17Reiterated Stifel Hold $31 → $35
Jan-26-17Reiterated RBC Capital Mkts Sector Perform $32 → $34
Jan-26-17Reiterated Aegis Capital Buy $36 → $38
Jan-24-17Reiterated The Benchmark Company Buy $39 → $37
Jan-03-17Resumed Piper Jaffray Neutral $28
Jan-03-17Initiated Aegis Capital Buy $36
Oct-21-16Upgrade Hilliard Lyons Long-term Buy → Buy
Oct-20-16Reiterated Wedbush Neutral $34 → $33
Oct-20-16Reiterated Mizuho Neutral $31 → $32
Oct-18-16Reiterated Monness Crespi & Hardt Buy $32 → $35
Oct-17-16Reiterated The Benchmark Company Buy $33 → $38
Oct-13-16Resumed Wedbush Neutral $34
Sep-29-16Upgrade Deutsche Bank Hold → Buy $30 → $40
Sep-14-16Reiterated Axiom Capital Buy $34 → $38
May-25-17 06:48PM  Fred Wilson throws a little cold water on bitcoin enthusiasts CNBC
May-24-17 03:13PM  Washington Post top editor: Bezos is a 'friendly' media billionaire Yahoo Finance
11:00AM  eBay Motors Crosses the Country with TV Host and Racing Analyst Rutledge Wood to Transform a 1967 Ford Mustang Fastback PR Newswire
07:00AM  2017 Global 2000: The World's Largest Transportation Companies Forbes
May-23-17 07:35AM  A Look at Alphabets MACD and RSI Market Realist
May-22-17 08:12AM  eBay (EBAY) Up 3.7% Since Earnings Report: Can It Continue? Zacks
May-20-17 01:18PM  3 Stocks That Look Just Like Google in 2004 Motley Fool
May-19-17 04:07PM  Oh Canada! Is Shopify A Buyer After Surprise Stock Offering? Investor's Business Daily
11:37AM  Better Buy: eBay Inc. vs. PayPal Motley Fool
09:05AM  How Twitters Market Cap Compares with Its Peers Market Realist
May-18-17 08:00AM  StubHub Reveals The Top 10 Canadian Music Tours Of Summer 2017 CNW Group
May-17-17 09:26AM  Analyst: Etsy Could Make Sense For eBay, But Sale Over Near Term Is Unlikely Benzinga
08:21AM  eBay's India Strategy Reveals a Major Weakness Motley Fool
May-16-17 08:57AM  eBay Motors and SHIFTMobility Partner to Drive Independent Repair Shop Parts Sales PR Newswire
08:37AM  The Partnership on AI adds Intel, Salesforce and others as it formalizes Grand Challenges and work groups TechCrunch
07:42AM  Don't Be Fooled by eBay's Surprisingly Low P/E Motley Fool
May-15-17 10:35AM  Chart in Focus: Looking at Snaps Valuation Multiples Market Realist
09:05AM  Snaps Technical Indicators: A Peer Comparison Market Realist
06:03AM  StubHub Reveals The Top 10 Music Tours Of Summer 2017 PR Newswire
May-14-17 12:10AM  [$$] UK eBay sellers to be forced to pay VAT on fees Financial Times
May-12-17 02:02PM  Why Shopify Inc. Stock Jumped 11.5% in April Motley Fool
May-11-17 11:05AM  eBay and TrueCar Collaborate for New Car Buying Service Zacks
09:00AM  StubHub Introduces New Skill for Microsoft Cortana to Make Event Discovery as Easy as Asking for Ideas PR Newswire
May-10-17 04:05PM  TrueCar partners with eBay Motors on new car buying program American City Business Journals
01:52PM  eBay resellers are making as much as $150,000 a year Yahoo Finance Video
09:54AM  EU to tackle complaints over tech companies' trading practices Reuters
09:40AM  EU to launch more e-commerce antitrust investigations Reuters
08:30AM  TrueCar Partners with eBay Motors to Launch a New Car Buying Program Business Wire
08:07AM  eBay, Inc. breached its 50 day moving average in a Bullish Manner : EBAY-US : May 10, 2017 Capital Cube
May-09-17 02:16PM  Here's Why Apple Pay Might Want to Roll Out a Welcome Mat for Alibaba's AliPay TheStreet.com
02:12PM  MercadoLibre Earnings Reveal a Sleeping Giant That's Waking Up Motley Fool
12:47PM  Cramer debates Wharton student on shorting PayPal CNBC Videos
12:38PM  Next generation of investors: 2017 Sohn Investment Idea w... CNBC Videos
07:30AM  JD.com's Earnings Suggest That Once Again, It Grew Faster Than Alibaba TheStreet.com
May-08-17 05:00AM  New Startups Aim to Be the EBays for Market Research Bloomberg
May-07-17 03:45PM  Can An eBay Executive Save Etsy? Will Wal-Mart Buy It? Analysts Weigh In Forbes
May-05-17 10:33AM  Is eBay Shopping for Shopify? Motley Fool
May-03-17 01:16PM  Craig Newmark Founded Craigslist To Give Back, Now He's A Billionaire Forbes
12:16PM  Big-name apps for Apple Watch seem to be disappearing David Pogue
09:06AM  How Much Is a Customer Worth to Alibaba? Market Realist
May-02-17 03:22PM  Is eBays Platform Evolution Bearing Fruit? Market Realist
02:53PM  Why Google, Amazon, Target & eBay yanked their Apple Watch apps Yahoo Finance Video
12:17PM  7 Fun Facts About PayPal (PYPL) As Stock Nears All-Time High Zacks
07:39AM  The Future for Alibabas Ant Financial Market Realist
06:00AM  Can Craigslist Be Killed? These Startups Are Taking Aim Forbes
May-01-17 09:15AM  StubHub Recognized By CIO As One Of The CIO 100 Award Winners PR Newswire
09:06AM  An Analysis of Amazons Market Capitalization Market Realist
Apr-28-17 07:00AM  Stanley Cup Playoffs Take a Toll on the Health of Canadians, StubHub Poll Finds CNW Group
Apr-27-17 03:41PM  PayPal's Strong Earnings Show That Its Dealmaking and Mobile Efforts Are Paying Off TheStreet.com
09:30AM  The Zacks Analyst Blog Highlights: Netflix, International Business Machines, Lam Research, eBay and Facebook Zacks
07:37AM  PayPal partnerships pay off, and Venmo could take off next MarketWatch
Apr-26-17 08:07PM  PayPal partnerships pay off, and Venmo could take off next MarketWatch
05:00PM  Tech Roundup: NFLX, IBM, LRCX, EBAY, FB Zacks
01:39PM  How Is Competition Impacting eBay's Average Spend Per User? Forbes
10:37AM  Will Amazon Ever Conquer Indias E-Commerce Market? Market Realist
06:59AM  What Are Online Marketplaces And What Is Their Future? Forbes
Apr-25-17 11:29PM  Bullish: No tech company is immune from discrimination and sexual harassment TechCrunch
03:31PM  ETFs with exposure to eBay, Inc. : April 25, 2017 Capital Cube
08:15AM  Post Earnings Coverage as eBay's Quarterly Revenue up 4%; Gross Merchandise Volume Grew 2% Accesswire
Apr-24-17 08:51PM  5 Things You Didn't Know About PayPal Holdings Inc. Motley Fool
10:19AM  eBay, Inc. :EBAY-US: Earnings Analysis: Q1, 2017 By the Numbers : April 24, 2017 Capital Cube
Apr-23-17 08:16PM  Labor calls for delay of GST collection on low-value imports ZDNet
Apr-21-17 11:26AM  eBay Slumps Despite Q1 Beat: Buy the Dip via ETFs? Zacks
09:13AM  eBay, Inc. breached its 50 day moving average in a Bearish Manner : EBAY-US : April 21, 2017 Capital Cube
08:00AM  Edited Transcript of EBAY earnings conference call or presentation 19-Apr-17 9:00pm GMT Thomson Reuters StreetEvents
12:53AM  ATO fails to rule out website blocking to enforce online GST collection ZDNet
Apr-20-17 04:39PM  Analysts See 250 Million Apple iPhone Shipments, Amazon Stock At 1,000 Investor's Business Daily
04:20PM  EBay Breaks 2 Key Technical Levels Despite Analyst Cheerleading Investor's Business Daily
04:17PM  AmEx Kicks Off Wall Street Rally, Mnuchin Tax Comments Keep it Going TheStreet.com
03:40PM  EBay analysts await big changes before diving in MarketWatch
03:15PM  Stocks Solidly Higher as Amex Earnings Fuel Good Vibes Over Reporting Season TheStreet.com
12:30PM  What Analysts Are Saying About eBay After Earnings 24/7 Wall St.
11:27AM  [$$] EBay Results Beat Expectations The Wall Street Journal
10:57AM  Amex Does Heavy Lifting on Dow, S&P 500 After Positive Earnings TheStreet.com
10:55AM  eBay (EBAY) Beats Earnings and Revenue Estimates in Q1 Zacks
10:48AM  Jim Cramer's Take on eBay, Whether to Buy Disney for ESPN TheStreet.com
09:55AM  Cramer's Stop Trading: DIS & EBAY CNBC Videos
09:00AM  Story Stocks from Briefing.com Briefing.com
08:41AM  Stock Futures Rise on Positive Earnings From Amex, Qualcomm TheStreet.com
08:22AM  Solid Start, Back-Half Tailwinds Support View on Ebay Morningstar
07:30AM  Investor Focus Shifts to Earnings Season: Today's Research Reports on eBay and American Express Accesswire
05:59AM  5 Things You Must Know Before the Market Opens Thursday TheStreet.com
12:39AM  Stocks Slide With Oil Prices The Wall Street Journal
12:31AM  Stock Futures Lean Higher: Can Dow Find Support? Investor's Business Daily
Apr-19-17 08:16PM  eBay Inc. Delivers Another Solid Quarter Motley Fool
07:18PM  EBay's second-quarter profit forecast falls short of estimates Reuters
06:24PM  Amazon vs eBay: Which should you buy? CNBC Videos
06:08PM  EBay, American Express, Qualcomm, CSX Move On Late Earnings Investor's Business Daily
06:07PM  eBay (EBAY) Posts Q1 Earnings Beat, Revenue Climbs 4% Zacks
05:47PM  eBay's Q1 beats expectations, shares slip on soft guidance ZDNet
05:03PM  EBay Delivers Mixed Earnings Benzinga
05:01PM  eBay Earnings Not Enough to Balance Out Weak Guidance 24/7 Wall St.
05:00PM  EBay Meets Revenue Forecast, Beats On Earnings Investor's Business Daily
04:57PM  EBay Struggles With Turnaround as Goliath Amazon Holds Sway Bloomberg
04:49PM  Ebay forecasts 2nd-qtr profit below estimates Reuters
04:39PM  eBay Slips: Q1 Revenue, EPS Beat; Q2 View Light; Affirms Year Outlook Barrons.com
04:36PM  EBay stock falls 2% after quarterly earnings MarketWatch
04:36PM  eBay Stock Tumbling After Latest Earnings TheStreet.com
04:35PM  Ebay Q1 GMV $20.9B CNBC Videos
04:34PM  EBay tops Street 1Q forecasts Associated Press
eBay Inc. operates commerce platforms that connect various buyers and sellers worldwide. Its platforms enable sellers to organize and offer their inventory for sale; and buyers to find and purchase it virtually. The company's Marketplace platforms include its online marketplace at ebay.com and the eBay mobile apps; and StubHub platforms comprise its online ticket platform at stubhub.com, and the StubHub mobile apps and Ticketbis platforms that connect fans with their favorite sporting events, shows, and artists, as well as enables them to buy and sell tickets. Its Classifieds platforms include a collection of brands, such as mobile.de, Kijiji, Gumtree, Marktplaats, eBay Kleinanzeigen, and others, which offer online classifieds to enable people find whatever they are looking for in their local communities. The company's platforms enable users to find, buy, sell, and pay for items through various online, mobile, and offline channels that include retailers, distributors, liquidators, import and export companies, auctioneers, catalog and mail-order companies, classifieds, directories, search engines, commerce participants, shopping channels, and networks. eBay Inc. was founded in 1995 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SWAN ROBERT HOLMESDirectorMay 25Sale35.0025,000875,000286,562May 26 06:13 PM
Mitic Kathleen C.DirectorMay 18Sale33.8411,897402,56811,456May 22 07:32 PM
Lee Jae HyunSVP, Asia PacificMay 16Sale34.5720,000691,30198,605May 19 05:20 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 12Sale34.112,90399,03030,701May 15 07:25 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 04Sale33.5712,904433,20833,604May 08 06:15 PM
Mitic Kathleen C.DirectorApr 27Option Exercise0.008,706023,353May 01 05:27 PM
SWAN ROBERT HOLMESDirectorApr 27Option Exercise0.008,7060310,961May 01 05:13 PM
Bates Anthony JohnDirectorApr 27Option Exercise0.008,706014,546May 01 05:07 PM
BARNHOLT EDWARD WDirectorApr 27Option Exercise0.008,706021,183May 01 05:33 PM
PRESSLER PAUL SDirectorApr 27Option Exercise0.008,706022,916May 01 05:37 PM
TRAQUINA PERRY MDirectorApr 27Option Exercise0.008,706018,666May 01 05:42 PM
TIERNEY THOMAS JDirectorApr 27Option Exercise0.0012,664035,175May 01 05:46 PM
ANDERSON FRED DDirectorApr 27Option Exercise0.008,706022,683May 01 06:14 PM
Hammer Bonnie SDirectorApr 27Option Exercise0.008,706012,417May 01 06:20 PM
FISHER STEPHENSVP, CTOApr 24Option Exercise21.648,273179,044113,108Apr 26 05:37 PM
FISHER STEPHENSVP, CTOApr 24Sale32.3533,0081,067,91980,100Apr 26 05:37 PM
FISHER STEPHENSVP, CTOApr 01Option Exercise0.0010,9190110,533Apr 03 08:36 PM
WENIG DEVINPresident and CEOApr 01Option Exercise0.0061,3920495,684Apr 03 08:32 PM
Doerger Brian J.VP, Chief Accounting OfficerApr 01Option Exercise0.0025,323057,174Apr 03 08:30 PM
Yetto Kristin ASVP, Chief People OfficerApr 01Option Exercise0.0012,903058,243Apr 03 08:26 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerApr 01Option Exercise0.0010,9730106,002Apr 03 08:23 PM
Lee Jae HyunSVP, Asia PacificApr 01Option Exercise0.0012,4280118,605Apr 04 08:54 PM
Schenkel Scott F.Chief Financial OfficerApr 01Option Exercise0.0019,4930109,778Apr 04 08:36 PM
Todd Jeremy PaulSVP, EMEAApr 01Option Exercise0.0017,168092,294Apr 04 08:29 PM
Huber Marie OhSVP, GC and SecretaryMar 15Option Exercise0.002,501042,811Mar 17 06:51 PM
Todd Jeremy PaulSVP, EMEAMar 15Option Exercise0.002,084076,232Mar 17 06:49 PM
Doerger Brian J.VP, Chief Accounting OfficerMar 15Option Exercise0.004,559033,565Mar 17 06:46 PM
Schenkel Scott F.Chief Financial OfficerMar 15Option Exercise0.006,252093,548Mar 17 06:43 PM
Lawton III Harry ASVP, North AmericaMar 15Option Exercise0.003,647038,350Mar 17 06:41 PM
Lee Jae HyunSVP, Asia PacificMar 15Option Exercise0.003,1260106,177Mar 17 06:38 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMar 15Option Exercise0.005,731098,020Mar 17 06:35 PM
FISHER STEPHENSVP, CTOMar 15Option Exercise0.007,2940103,421Mar 17 06:32 PM
Yetto Kristin ASVP, Chief People OfficerMar 15Option Exercise0.003,126046,972Mar 17 06:29 PM
WENIG DEVINPresident and CEOMar 15Option Exercise0.0013,0860441,121Mar 17 06:26 PM
Huber Marie OhSVP, GC and SecretaryMar 01Option Exercise0.0037,870040,310Mar 03 07:06 PM
Lee Jae HyunSVP, Asia PacificMar 01Option Exercise0.0026,2040103,051Mar 03 06:59 PM
Yetto Kristin ASVP, Chief People OfficerMar 01Option Exercise0.0049,538058,198Mar 03 06:48 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMar 01Option Exercise0.0032,7540111,597Mar 03 06:26 PM
FISHER STEPHENSVP, CTOMar 01Option Exercise0.0045,8560135,543Mar 03 06:02 PM
Todd Jeremy PaulSVP, EMEAMar 01Option Exercise0.0013,103081,212Mar 03 07:24 PM
Lawton III Harry ASVP, North AmericaMar 01Option Exercise0.0037,870052,390Mar 03 07:12 PM
Lee Jae HyunSVP, Asia PaificFeb 27Sale33.986,375216,62976,847Mar 01 05:08 PM
Lawton III Harry ASVP, North AmericaFeb 23Sale33.7313,400451,92214,520Feb 27 07:49 PM
FISHER STEPHENSVP, CTOFeb 22Option Exercise21.6416,543358,02199,657Feb 23 06:33 PM
FISHER STEPHENSVP, CTOFeb 22Sale33.7716,601560,62189,687Feb 23 06:33 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerFeb 17Option Exercise23.0810,974253,27885,966Feb 21 07:40 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerFeb 17Sale33.6630,0101,010,00477,879Feb 21 07:40 PM
Lee Jae HyunSVP, Asia PacificFeb 16Sale34.118,000272,88483,222Feb 21 07:35 PM
Doerger Brian J.VP, Chief Accounting OfficerFeb 09Sale33.256,660221,43229,006Feb 10 05:21 PM
TIERNEY THOMAS JDirectorFeb 08Option Exercise9.856,01459,23828,525Feb 09 07:38 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaFeb 08Option Exercise22.6253,1271,201,614117,972Feb 10 05:15 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaFeb 08Sale32.7853,1271,741,57291,222Feb 10 05:15 PM
TIERNEY THOMAS JDirectorFeb 08Sale33.286,014200,15722,511Feb 09 07:38 PM
SWAN ROBERT HOLMESDirectorJan 30Option Exercise22.69125,6082,850,288442,401Jan 31 06:03 PM
SWAN ROBERT HOLMESDirectorJan 30Sale32.00200,6086,418,532301,633Jan 31 06:03 PM
Yetto Kristin ASVP, Chief People OfficerDec 15Option Exercise0.003,126023,966Dec 16 07:57 PM
FISHER STEPHENSVP, CTODec 15Option Exercise0.007,294093,552Dec 16 07:51 PM
WENIG DEVINPresident and CEODec 15Option Exercise0.0013,0860472,666Dec 16 07:47 PM
Schenkel Scott F.Chief Financial OfficerDec 15Option Exercise0.006,2520104,017Dec 19 07:48 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerDec 15Option Exercise0.00137,6430169,703Dec 19 07:38 PM
Lee Jae HyunSVP, Asia PacificDec 15Option Exercise0.003,126091,222Dec 19 07:32 PM
Doerger Brian J.VP, Chief Accounting OfficerDec 15Option Exercise0.0018,487045,313Dec 19 07:28 PM
Lawton III Harry ASVP, North AmericaDec 15Option Exercise0.003,647029,824Dec 19 07:23 PM
Huber Marie OhSVP, GC and SecretaryDec 15Option Exercise0.002,501022,079Dec 19 07:17 PM
Todd Jeremy PaulSVP, EMEADec 15Option Exercise0.002,084069,233Dec 19 07:09 PM
Doerger Brian J.VP, Chief Accounting OfficerNov 21Option Exercise22.8818,000411,87644,826Nov 23 07:13 PM
Doerger Brian J.VP, Chief Accounting OfficerNov 21Sale28.9318,000520,79626,826Nov 23 07:13 PM
Green LoganDirectorNov 02Buy28.321,00028,3211,000Nov 03 08:02 PM
FISHER STEPHENSVP, CTOOct 25Option Exercise21.6412,408268,532120,563Oct 26 07:50 PM
FISHER STEPHENSVP, CTOOct 25Sale29.2039,7641,161,10986,258Oct 26 07:50 PM
FISHER STEPHENSVP, CTOOct 15Option Exercise0.00106,5490169,212Oct 17 06:42 PM
Schenkel Scott F.SVP, Chief Financial OfficerOct 15Option Exercise0.005,9070100,848Oct 17 06:37 PM
WENIG DEVINPresident and CEOOct 15Option Exercise0.0013,8980466,832Oct 17 06:32 PM
Yetto Kristin ASVP, Chief People OfficerSep 15Option Exercise0.003,126022,472Sep 19 06:23 PM
Todd Jeremy PaulSVP, EMEASep 15Option Exercise0.002,084068,280Sep 19 06:06 PM
Schenkel Scott F.SVP, Chief Financial OfficerSep 15Option Exercise0.006,252098,204Sep 19 06:00 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerSep 15Option Exercise0.005,731035,051Sep 19 05:54 PM
Lee Jae HyunSVP, Asia PacificSep 15Option Exercise0.003,126088,096Sep 19 05:49 PM
Lawton III Harry ASVP, North AmericaSep 15Option Exercise0.003,647028,081Sep 19 05:44 PM
Huber Marie OhSVP, GC and SecretarySep 15Option Exercise0.002,500020,883Sep 19 05:32 PM
FISHER STEPHENSVP, CTOSep 15Option Exercise0.007,294066,470Sep 19 05:22 PM
Doerger Brian J.VP, Chief Accounting OfficerSep 15Option Exercise0.004,558029,205Sep 19 05:16 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerAug 31Option Exercise22.7141,880951,13948,779Sep 01 05:49 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerAug 31Sale32.1439,0301,254,56526,980Sep 01 05:49 PM
Lee Jae HyunSVP, Asia PacificAug 31Sale31.8516,559527,42684,970Sep 02 04:58 PM
SWAN ROBERT HOLMESDirectorAug 30Sale31.9550,0001,597,500375,928Sep 01 05:27 PM
Lee Jae HyunSVP, Asia PacificAug 24Sale31.025,625174,488101,529Aug 26 06:40 PM
Todd Jeremy PaulSVP, EMEAAug 10Option Exercise0.0032,935084,065Aug 12 05:06 PM
Lee Jae HyunSVP, Asia PacificJul 27Sale31.533,222101,590107,154Jul 28 08:15 PM
Lee Jae HyunSVP, Asia PacificJul 26Sale31.0310,601328,949110,376Jul 27 06:40 PM
Doerger Brian J.VP, Chief Accounting OfficerJul 25Option Exercise22.6313,608307,94948,605Jul 27 06:19 PM
FISHER STEPHENSVP, CTOJul 25Option Exercise21.6437,223805,57797,032Jul 27 06:58 PM
TIERNEY THOMAS JDirectorJul 25Option Exercise9.858,00078,80025,545Jul 27 07:13 PM
SWAN ROBERT HOLMESDirectorJul 25Sale30.6550,0001,532,340425,288Jul 27 07:06 PM
FISHER STEPHENSVP, CTOJul 25Sale30.6553,3891,636,16959,176Jul 27 06:58 PM
Lee Jae HyunSVP, Asia PacificJul 25Sale30.741,16735,878120,977Jul 27 06:40 PM
Yetto Kristin ASVP, Chief People OfficerJul 25Sale30.7917,596541,83419,346Jul 27 06:34 PM
Doerger Brian J.VP, Chief Accounting OfficerJul 25Sale30.5623,958732,26424,647Jul 27 06:19 PM
TIERNEY THOMAS JDirectorJul 25Sale30.658,000245,20017,545Jul 27 07:13 PM
Schenkel Scott F.SVP, Chief Financial OfficerJul 17Option Exercise0.001,768092,875Jul 18 08:27 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E24.62 EPS (ttm)1.09 Insider Own0.30% Shs Outstand2.16B Perf Week-0.81%
Market Cap57.95B Forward P/E16.98 EPS next Y1.58 Insider Trans0.28% Shs Float1.45B Perf Month-0.88%
Income2.60B PEG2.85 EPS next Q0.34 Inst Own37.20% Short Float1.42% Perf Quarter-3.20%
Sales25.34B P/S2.29 EPS this Y-20.90% Inst Trans1.79% Short Ratio5.05 Perf Half Y4.51%
Book/sh10.62 P/B2.53 EPS next Y11.31% ROA5.00% Target Price32.96 Perf Year-2.00%
Cash/sh0.03 P/C918.41 EPS next 5Y8.63% ROE11.80% 52W Range24.01 - 30.25 Perf YTD-0.55%
Dividend1.66 P/FCF- EPS past 5Y-3.30% ROI7.80% 52W High-11.11% Beta0.92
Dividend %6.17% Quick Ratio0.50 Sales past 5Y-12.30% Gross Margin13.80% 52W Low11.99% ATR0.43
Employees6800 Current Ratio0.80 Sales Q/Q46.30% Oper. Margin14.60% RSI (14)46.59 Volatility1.35% 1.66%
OptionableYes Debt/Eq1.04 EPS Q/Q9.90% Profit Margin10.30% Rel Volume1.23 Prev Close27.06
ShortableYes LT Debt/Eq0.94 EarningsMay 02 BMO Payout130.50% Avg Volume4.07M Price26.89
Recom1.60 SMA20-0.50% SMA50-1.56% SMA200-0.54% Volume5,015,435 Change-0.63%
Apr-18-17Initiated Guggenheim Buy
Jan-31-17Reiterated Barclays Overweight $31 → $33
Nov-16-16Initiated Ladenburg Thalmann Buy
Sep-30-16Initiated Mizuho Buy $32
Sep-19-16Upgrade Credit Suisse Neutral → Outperform
Aug-31-16Reiterated Wunderlich Buy $33 → $32
Aug-18-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Jun-03-14Initiated Global Hunter Securities Buy $83
May-02-14Reiterated Stifel Buy $75 → $78
May-27-17 07:04AM  The 1 Stock I'd Never Put in an IRA Motley Fool
May-26-17 10:36AM  ETE, EPD, KMI, WMB: Analysts Are Bullish on the Midstream Giants Market Realist
09:06AM  ETE, EPD, KMI, and WMB: What the Current Valuations Indicate Market Realist
08:29AM  Enterprise Products Partners LP breached its 50 day moving average in a Bearish Manner : EPD-US : May 26, 2017 Capital Cube
07:35AM  Are Institutional Investors Bullish on EPD, ETE, KMI, and WMB? Market Realist
May-25-17 09:06AM  ETE, EPD, KMI, and WMB: A Leverage Comparison after 1Q17 Market Realist
08:52AM  Enterprise Products to Participate in Annual MLPA Investor Conference Business Wire
07:35AM  Analyzing Energy Transfer Equitys High Leverage Market Realist
May-24-17 10:36AM  Energy Transfer Equity Had $43 Billion in Debt at the End of 1Q17 Market Realist
09:49AM  My 3 Biggest Stock Holdings Motley Fool
09:06AM  KMI, WMB Expect Higher Capital Spending in 2017 Market Realist
07:36AM  What Enterprise Products Could Offer Income Investors Market Realist
May-23-17 12:00PM  3 Top-Notch High-Yield Stocks to Buy Right Now Motley Fool
10:38AM  ETE, EPD, KMI, and WMB: Analyzing Earnings Growth in 2017 Market Realist
09:08AM  Analyzing Revenue Growth of ETE, EPD, KMI, and WMB in 2017 Market Realist
09:07AM  Short Interest in Enterprise Products Rose Marginally in May Market Realist
07:39AM  Enterprise Products Partners Is Outperforming Peers in 2017 Market Realist
07:38AM  What EPDs Implied Volatility Suggests about Its Price This Week Market Realist
May-22-17 05:36PM  What Analysts Recommend for Enterprise Products Partners Market Realist
04:03PM  Enterprise Products Partners Ended Flat Last Week Market Realist
07:38AM  Analysts Recommendations for Energy Transfer Partners Market Realist
May-19-17 12:05PM  Energy Transfer Partners Value Compared to Its Peers Market Realist
May-18-17 11:00AM  Roundtable: 1 Stock I'm Never Selling Motley Fool
May-16-17 05:00PM  Enterprise Products to Participate in MUFG Securities Americas Inc. Oil and Gas Conference Business Wire
11:27AM  2 Stocks That Pay You Big Distributions Motley Fool
10:38AM  Is Enterprise Products Partners Fairly Valued? Market Realist
09:08AM  Short Interest in Enterprise Products Stock Rises Marginally Market Realist
07:39AM  How EPD May Perform This Week Based on Its Implied Volatility Market Realist
May-15-17 06:05PM  Whats ahead for Enterprise Products Partners Stock? Market Realist
04:28PM  Enterprise Products Partners Closed Last Week with Marginal Gains Market Realist
May-14-17 10:42AM  3 High-Yield Dividend Stocks for May Motley Fool
May-13-17 08:12AM  3 Winning Stocks You Never Saw Coming Motley Fool
May-09-17 09:01PM  Edited Transcript of EPD earnings conference call or presentation 2-May-17 2:00pm GMT Thomson Reuters StreetEvents
05:00PM  Will New Pipelines Be Enough To Handle The Permian Boom? Oilprice.com
May-08-17 08:38PM  5 MLPs Likely to do Best When Crude Rebounds Barrons.com
09:06AM  Which MLPs Look Safe amid Crude Oil Uncertainty? Market Realist
08:00AM  Enterprise Products to Participate in Deutsche Bank MLP, Midstream, & Natural Gas Conference Business Wire
07:37AM  Where Are MLPs Currently Trading Compared to Historical Levels? Market Realist
May-03-17 04:06PM  Inside ONEOKs 1Q17 Earnings: Key Drivers Market Realist
10:23AM  Enterprise Product Partners (EPD) Q1 Earnings & Revenue Beat Zacks
07:35AM  Is Plains All American Pipeline Overvalued? Market Realist
May-02-17 01:35PM  Enterprise Products Partners: More Demand for Energy Commodities Market Realist
01:17PM  Enterprise Products Partners Shakes Off Several Quarters of Flat Results, Boasts a Strong First Quarter Motley Fool
12:01PM  What Drove Enterprise Products Partners 1Q17 Earnings Growth? Market Realist
12:01PM  Enterprise Products Partners 1Q17 EBITDA Rose 6.6% Market Realist
09:10AM  How Oneoks Current Valuation Compares with Its Peers Market Realist
06:21AM  Enterprise Products beats 1Q profit forecasts Associated Press
06:00AM  Enterprise Reports Results for First Quarter 2017 Business Wire
May-01-17 03:02PM  Oneok Stock Fell 1.7% Last Week, Underperformed Energy Sector Market Realist
09:00AM  Should You Sell Enterprise Products Partners (EPD) Before Earnings? Zacks
Apr-28-17 10:45AM  Enterprise Completes Acquisition of Azure Natural Gas Gathering System Business Wire
Apr-26-17 02:14PM  Trump's tax cut proposal shines light on MLPs Reuters
12:17PM  Enterprise Products Partners LP : EPD-US: Dividend Analysis : April 28th, 2017 (record date) : By the numbers : April 26, 2017 Capital Cube
09:25AM  3 Dividend Stocks That Prove Boring Is Beautiful Motley Fool
Apr-25-17 03:05PM  What Might Drive Enterprise Products Partners 1Q17 Earnings? Market Realist
01:19PM  Enterprise Products Partners 1Q17 Earnings Are Expected to Rise Market Realist
09:08AM  What Enterprise Products Partners Valuation Shows Market Realist
09:07AM  Enterprise Products Partners LP breached its 50 day moving average in a Bullish Manner : EPD-US : April 25, 2017 Capital Cube
07:38AM  Analyzing Short Interest in Enterprise Products Partners Stock Market Realist
Apr-24-17 05:35PM  What EPDs Low Implied Volatility Means for Its Stock Price Market Realist
04:05PM  Will Enterprise Products Partners Stock Gain Strength? Market Realist
02:06PM  Despite Oils Plunge, Enterprise Products Closed the Week Flat Market Realist
Apr-21-17 07:37AM  Kinder Morgans 1Q17 Net Income Falls 9%, Misses Estimates Market Realist
Apr-20-17 11:46AM  EnLink Midstream Partners Implied Volatility Rose the Most Market Realist
11:06AM  Better Buy: Enterprise Products Partners L.P. vs. Buckeye Partners, L.P. Motley Fool
07:36AM  What Does ONEOKs Current Valuation Indicate? Market Realist
Apr-18-17 05:05PM  How Williams Partners Expects to Benefit from Geismar Plant Sale Market Realist
10:37AM  What Does Kinder Morgans Valuation Indicate? Market Realist
Apr-17-17 08:15AM  Blog Coverage ConocoPhillips Nets $3 Billion from Sale of San Juan Basin Assets to Hilcorp Energy Accesswire
Apr-15-17 09:16AM  2 Top Dividend Stocks for Low-Risk Investors Motley Fool
Apr-13-17 11:08AM  Love Dividends? Here's 4 Energy Sector Stocks You Might Want to Buy Motley Fool
10:00AM  I Still Can't Believe Enterprise Products Partners L.P. Spent $189 million on This Bankrupt Company Motley Fool
Apr-12-17 01:23PM  Enterprise Products Partners LP Value Analysis (NYSE:EPD) : April 12, 2017 Capital Cube
08:58AM  Enterprise Sets Record for Volumes at Texas Gulf Coast Marine Terminals Business Wire
Apr-11-17 10:46AM  Enterprise to Build 571 Mile Pipeline from Permian Basin Zacks
10:11AM  2 Energy Stocks I'd Buy Right Now Motley Fool
08:20AM  Enterprise Products Partners LP breached its 50 day moving average in a Bullish Manner : EPD-US : April 11, 2017 Capital Cube
07:37AM  Is Enterprise Products Partners Fairly Valued? Market Realist
Apr-10-17 03:05PM  Analyzing Short Interest in Enterprise Products Partners Stock Market Realist
02:15PM  Enterprise Products Partners to build 571-mile NGL pipeline American City Business Journals
01:35PM  What to Expect from Enterprise Products Partners Stock Market Realist
12:00PM  Is Enterprise Products Partners Stock Gaining Strength? Market Realist
11:59AM  Enterprise Products Partners Raised Its 1Q17 Distribution Market Realist
08:30AM  Enterprise to Build Shin Oak NGL Pipeline from Permian Basin to Mont Belvieu, Texas Business Wire
Apr-08-17 12:00PM  Top Fracking Stocks to Buy in 2017 Motley Fool
Apr-07-17 02:39PM  Enterprise Products Partners: Look for a Resolution to the Upside TheStreet.com
07:24AM  In the midst of an oil-price slump, one area in Texas is enjoying a bit of a boom MarketWatch
Apr-06-17 02:36PM  MLPs with the Maximum Potential Upside after 1Q17 Market Realist
10:09AM  Enterprise Products Announces Quarterly Distribution Hike Zacks
08:24AM  3 Stocks We'd Buy and Hold for the Next 20 Years Motley Fool
06:26AM  [$$] Why the Texas natural gas boom is making waves Financial Times
Apr-05-17 08:51AM  Enterprise Declares Quarterly Distribution Increase Business Wire
Apr-04-17 04:20PM  Houston company to build ethylene storage, pipeline projects American City Business Journals
10:29AM  Enterprise Products Partners to Expand Ethylene Projects Zacks
07:37AM  Is ONEOK Stock Fairly Valued? Market Realist
Apr-03-17 02:33PM  These 6 Energy Names Are Big Holdings of the Most MLP Funds Barrons.com
12:05PM  Kinder Morgan Stock Gains Strength, but Can It Keep It Up? Market Realist
08:30AM  Enterprise to Develop Ethylene Storage and Transportation Projects Business Wire
Mar-31-17 12:14PM  5 Things You Didn't Know About Enterprise Products Partners L.P. Motley Fool
08:30AM  Enterprise Products Partners to Participate in Mizuho Energy Infrastructure Conference Business Wire
Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment offers natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,670 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas and ethane export terminals, and related operations. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 440 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,120 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 686 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates approximately 4,250 miles of refined products pipelines; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Edwin EAdvisory DirectorMar 06Sale28.0215,000420,300420,654Mar 06 05:18 PM
HACKETT JAMES TDirectorFeb 03Buy28.6533,000945,45033,000Feb 06 04:14 PM
BARTH CARIN MARCYDirectorNov 16Buy25.274,000101,08013,126Nov 16 04:50 PM
VRX Valeant Pharmaceuticals International, Inc. daily Stock Chart
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-4.04 Insider Own2.30% Shs Outstand340.23M Perf Week-5.10%
Market Cap4.37B Forward P/E3.30 EPS next Y3.89 Insider Trans-70.31% Shs Float337.68M Perf Month36.78%
Income-1407.30M PEG- EPS next Q0.98 Inst Own66.80% Short Float16.04% Perf Quarter-23.22%
Sales9.41B P/S0.46 EPS this Y-714.90% Inst Trans20.75% Short Ratio2.17 Perf Half Y-24.26%
Book/sh11.13 P/B1.15 EPS next Y7.02% ROA-3.10% Target Price- Perf Year-52.38%
Cash/sh3.56 P/C3.61 EPS next 5Y-7.26% ROE-34.10% 52W Range8.31 - 32.74 Perf YTD-11.64%
Dividend- P/FCF2.72 EPS past 5Y61.43% ROI-1.60% 52W High-60.82% Beta-0.34
Dividend %- Quick Ratio1.00 Sales past 5Y31.90% Gross Margin72.60% 52W Low54.38% ATR0.67
Employees21500 Current Ratio1.30 Sales Q/Q-11.10% Oper. Margin-5.20% RSI (14)57.83 Volatility3.64% 6.19%
OptionableYes Debt/Eq7.33 EPS Q/Q265.40% Profit Margin-15.00% Rel Volume0.36 Prev Close12.79
ShortableYes LT Debt/Eq7.24 EarningsMay 09 BMO Payout- Avg Volume24.92M Price12.83
Recom3.00 SMA206.15% SMA5018.49% SMA200-25.81% Volume8,875,119 Change0.31%
May-10-17Reiterated RBC Capital Mkts Sector Perform $18 → $19
Apr-20-17Reiterated JP Morgan Neutral $15 → $10
Mar-23-17Reiterated RBC Capital Mkts Sector Perform $21 → $18
Mar-06-17Reiterated Rodman & Renshaw Neutral $23 → $17
Feb-27-17Reiterated Mizuho Underperform $11 → $9
Feb-14-17Reiterated RBC Capital Mkts Sector Perform $29 → $22
Feb-10-17Reiterated Barclays Equal Weight $34 → $20
Jan-04-17Reiterated Piper Jaffray Underweight $16 → $11
Dec-15-16Downgrade Morgan Stanley Overweight → Equal-Weight $25 → $17
Nov-23-16Downgrade Mizuho Neutral → Underperform $25 → $11
Nov-14-16Reiterated Deutsche Bank Hold $29 → $24
Nov-10-16Reiterated Morgan Stanley Overweight $42 → $25
Nov-10-16Downgrade Rodman & Renshaw Buy → Neutral $81 → $23
Nov-09-16Reiterated RBC Capital Mkts Sector Perform $35 → $29
Oct-14-16Reiterated Deutsche Bank Hold $30 → $29
Oct-12-16Reiterated RBC Capital Mkts Sector Perform $36 → $35
Sep-20-16Resumed Deutsche Bank Hold $30
Aug-17-16Upgrade Morgan Stanley Equal-Weight → Overweight $33 → $42
Aug-15-16Upgrade Mizuho Underperform → Neutral $11 → $25
Aug-10-16Reiterated RBC Capital Mkts Sector Perform $31 → $36
May-26-17 10:53AM  Top 3 Companies Owned by Valeant (VRX) Investopedia
May-25-17 11:46AM  Valeant's Numbers: Are They As Good As They Seem? Motley Fool
May-23-17 02:06PM  Valeant and Gilead: Beaten Down Bargains or Truly Terrible? Motley Fool
12:56PM  Time to Buy Valeant Pharmaceuticals Investopedia
May-22-17 08:27AM  3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter Motley Fool
08:25AM  Eyegate Pharma stock surges 11% after receiving Valeant milestone payment MarketWatch
07:30AM  Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution PR Newswire
07:30AM  Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution CNW Group
May-21-17 09:04AM  3 Value Stocks for Ambitious Investors Motley Fool
May-20-17 12:47PM  Ackman has something to prove after Valeant mistake MarketWatch
May-19-17 04:50PM  Bill Ackman Details Missteps With Valeant Investment TheStreet.com
01:33PM  Valeant Pharmaceuticals: IntriguedReally? Barrons.com
09:48AM  Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA Zacks
07:23AM  5 Things You Must Know Before the Market Opens Friday TheStreet.com
03:24AM  Bill Ackman has something to prove after Valeant mistake MarketWatch
May-18-17 10:04PM  Humbled by Valeant, Ackman goes back to basics Reuters
09:15PM  SALT Spotlight: Ackman Explains His Valeant 'Mistake' Barrons.com
10:43AM  It's the Truth: Valeant Pharmaceuticals' Debt Situation Is Worse Now Than a Year Ago Motley Fool
May-17-17 02:23PM  Pershing Square Trims Mondelez, APD and Obviously Valeant: 13F Filing Investopedia -5.89%
01:00PM  Stocks Billionaire Bill Ackman Is Selling Now Motley Fool
12:11PM  Biotech And Pharma Industry And Stock News Investor's Business Daily
10:01AM  Allergan's Irritable Bowel Drug Viberzi Approved in Canada Zacks
09:07AM  3 Brand-Name Stocks That Billionaire Money Managers Ditched in the First Quarter Motley Fool
07:20AM  Valeant and Actavis agree to stay litigation relating to Valeant's top-selling drug Xifaxan MarketWatch
07:00AM  Statement Regarding Xifaxan Intellectual Property Litigation PR Newswire
May-16-17 09:54AM  Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka Zacks
12:32AM  [$$] ValueActs Jeffrey Ubben Hands Reins to Protégé Mason Morfit The Wall Street Journal
May-15-17 06:20PM  Safirstein Metcalf LLP and HGT Law Updates Investors on Valeant Pharmaceuticals International Inc. Investor Class Action - VRX GlobeNewswire
04:54PM  ETFs with exposure to Valeant Pharmaceuticals International, Inc. : May 15, 2017 Capital Cube
04:05PM  The short seller who uncovered Valeant has found his next target in health care CNBC
03:34PM  [$$] Ubben steps down as investment head at ValueAct Financial Times
09:54AM  Valeant Pharmaceuticals: Why One Bear is Staying Bearish Barrons.com
May-14-17 10:03AM  Weekend roundup: Good and bad company earnings | Sound investing advice | Crumbling support for Putin MarketWatch
May-12-17 04:08PM  Court Battle May Be Responsible For Drugmaker's 40% Spike Investor's Business Daily
12:52PM  Valeant Pharmaceuticals: Living to Fight Another Day? Barrons.com
10:38AM  Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 Capital Cube
10:07AM  Company News for May 12, 2017 Zacks
09:31AM  Why prescription drug prices keep going up Yahoo Finance
07:22AM  Is This the Real Reason Valeant's Shares Are Skyrocketing? Motley Fool
07:00AM  6 Hot Stock Charts WIth Unusual Volume TheStreet.com
May-11-17 07:51PM  Valeant Pharmaceuticals International, Inc. Value Analysis (NYSE:VRX) : May 11, 2017 Capital Cube +8.83%
05:57PM  The 2 Likely Reasons Valeant Pharmaceuticals Surged by as Much as 15% Motley Fool
10:16AM  Valeant Pharmaceuticals: Feeling Sentimental? Barrons.com
May-10-17 05:02PM  Valeant Rockets Higher: Why I'm Not Buying Motley Fool +5.23%
05:00PM  Valeant Pharmaceuticals To Present At Health Care Conferences PR Newswire
05:00PM  Valeant Pharmaceuticals To Present At Health Care Conferences CNW Group
03:48PM  Valeant (VRX) Q1 Earnings & Revenues Miss, View Raised Zacks
12:09PM  Valeant Expresses Confidence In Outlook, But Might Be Too Early To Get Bullish Benzinga
10:15AM  Valeant Pharmaceuticals: The End of the Beginning? Barrons.com
09:22AM  Valeant Pharmaceuticals' Q1 Report Might Be the Greatest Smoke-and-Mirrors Show You'll Ever See Motley Fool
08:18AM  Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-US : May 10, 2017 Capital Cube
08:00AM  Today's Research Reports on Stocks to Watch: Endo International and Valeant Pharmaceuticals Accesswire
06:59AM  Valeant shares rocket 24% as investors cheer moves to reduce debt MarketWatch
May-09-17 06:24PM  Valeant Shows Signs Its Turnaround Efforts Are Bearing Fruit; Jim Cramer Weighs In TheStreet.com +24.10%
06:23PM  Valeant Moves Its Debt Pile, Gets Some Breathing Room TheStreet.com
05:21PM  CANADA STOCKS-TSX down as banks and energy weigh; Valeant, Home Capital soars Reuters
05:18PM  Valeant Surges While Analysts Remain Cautious Bloomberg
04:29PM  Why Sturm Ruger, Wayfair, and Valeant Pharmaceuticals Jumped Today Motley Fool
04:16PM  CANADA STOCKS-TSX dragged by banks and energy; Valeant, Home Capital surges Reuters
02:43PM  Why Valeant Pharmaceuticals Stock Is Soaring Today Motley Fool
02:40PM  Valeant: Is That All? Barrons.com
01:43PM  Trader: Investors should watch Valeant's core business CNBC Videos
01:28PM  Valeant Can't Paper Over Its Problems Bloomberg
12:23PM  Valeant Pharmaceuticals Raises Full-Year Outlook After Posting a First-Quarter Profit Motley Fool
11:56AM  [$$] Valeant shares jump as it lifts full-year earnings guidance Financial Times
11:22AM  Drugmaker Valeant raises profit forecast; shares spike Reuters
11:12AM  Valeant turns First Profit in Six Quarters Investopedia
10:48AM  Valeant swings to a profit Reuters Videos
09:56AM  Valeant: Up, Up & Away! Barrons.com
09:52AM  US STOCKS-S&P, Nasdaq hit record highs as volatility drops Reuters
09:49AM  CANADA STOCKS-TSX dips as losses for energy offset Home Capital, Valeant Reuters
09:27AM  Biotech Movers: Valeant Shares Jump After Raising Adjusted Ebitda Outlook TheStreet.com
09:01AM  US STOCKS-Wall St set to open higher as risk-on sentiment improves Reuters
08:44AM  Morning News Call Canadienne - Mai 9 Reuters
08:37AM  Valeant explodes after boosting guidance Business Insider
08:29AM  Morning Movers: Valeant Surges, Hertz Tumbles, Marriott Jumps Barrons.com
08:28AM  Drugmaker Valeant tops 1Q profit forecasts, chops debt again Associated Press
08:22AM  TransDigm Results May Mitigate Shortselling Concerns TheStreet.com
08:00AM  Valeant Pharmaceuticals Pipeline, Catalysts and Price Targets Accesswire
07:45AM  How Valeant Earnings Beat Estimates 24/7 Wall St.
07:14AM  Valeant's stock soars after profit beats expectations MarketWatch
07:00AM  Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range CNW Group
May-08-17 06:47PM  Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Solution, 0.025% PR Newswire
06:47PM  Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Solution, 0.025% CNW Group
06:15PM  Valeant Pharmaceuticals Reports Tomorrow Morning, and This Is the Only Number That Matters Motley Fool
04:57PM  Bill Ackman Comments on Valeant in Annual Shareholder Letter GuruFocus.com
04:24PM  Bill Ackman's 2017 Shareholder Letter and Portfolio Commentary GuruFocus.com
12:42PM  Pershing Shows It Isn't Done With The Biotech World After Valeant Benzinga
12:19PM  5 Earnings Short-Squeeze Plays: Snap, NVIDIA & More TheStreet.com
11:29AM  More Trouble Ahead For Valeant? Barrons.com
May-07-17 10:25AM  Disney, Snap, Whole Foods and More Key Earnings Reports Coming This Week 24/7 Wall St.
10:05AM  Earnings Preview: What To Expect From Valeant Pharmaceuticals On Tuesday Forbes
May-05-17 06:08PM  Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership PR Newswire
02:41PM  What to Expect From Valeant Pharmaceuticals' Q1 Results Motley Fool
08:47AM  Implied Volatility Surging for Valeant Pharmaceuticals (VRX) Stock Options Zacks
May-04-17 09:57AM  Valeant: When Earnings are Almost an Afterthought Barrons.com
09:43AM  Shocker: Valeant Pharmaceuticals Slides Another 16% in April. Here's the Big Reason Why Motley Fool
May-03-17 06:02PM  Valeant Announces 2017 Annual Meeting Results CNW Group
04:26PM  Ackman's Pershing Square to Be Listed on London Stock Exchange Investopedia
06:00AM  10 Solid Value Stocks at Great Prices (and 10 to Pass Up) Morningstar
Valeant Pharmaceuticals International, Inc. operates as a pharmaceutical and medical device company worldwide. It operates in three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The company offers Lotemax gel for the treatment of inflammation and pain following ocular surgery; Ocuvite, a lutein eye vitamin and mineral supplement; PreserVision, an antioxidant eye vitamin and mineral supplement; ReNu Multiplus products; Biotrue multi-purpose solution for healthy contact lens wear; Artelac to treat dry eyes; Boston, a cleansing solution for gas permeable contact lenses; and Bedoyecta, a vitamin B complex. It also provides SofLens daily disposable contact lenses; ophthalmic surgical products; PureVision, a silicone hydrogel; Biotrue ONEday daily disposable contact lenses; Bausch + Lomb Ultra, a silicone hydrogel replacement contact lens; and medical device systems. In addition, the company offers Xifaxan for the treatment of irritable bowel syndrome; Provenge for the treatment of prostate cancer; Uceris to get ulcerative colitis under control; Arestin, a subgingival sustained-release antibiotic; Jublia for the treatment of onychomycosis; Solodyn for the treatment of acne; Elidel to treat skin conditions; and Glumetza tablets to enhance glycemic control. Further, it provides Wellbutrin XL for the treatment of major depressive disorder; Isuprel injections; Xenazine for the treatment of chorea; Nitropress for the reduction of blood pressure of patients in hypertensive crises; Cuprimine to treat Wilson's disease; Zegerid to treat certain stomach and esophagus problems; Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; and Latanoprost medicines to treat a type of glaucoma. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1983 and is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DE SCHUTTER RICHARD UDirectorMay 11Buy13.9020,000278,00070,572May 15 05:19 PM
DE SCHUTTER RICHARD UDirectorMar 15Buy10.8010,000108,00025,190Mar 16 05:12 PM
Herendeen PaulEVP and CFOMar 14Buy10.7224,000257,280174,000Mar 16 05:04 PM
ValueAct Holdings, L.P.DirectorMar 14Buy10.823,000,00032,465,00016,937,431Mar 16 04:31 PM
Pershing Square Capital ManageDirectorMar 13Sale11.0018,114,432199,258,7520Mar 14 04:14 PM
Ross Thomas W. Sr.DirectorDec 14Buy14.735,00073,65026,822Dec 16 04:19 PM
Pershing Square Capital ManageDirectorDec 12Sale14.853,476,69051,628,84718,114,432Dec 13 04:14 PM
KARABELAS ARGERIS NDirectorAug 11Buy24.654,00098,60020,726Aug 12 04:37 PM
Ross Thomas W. Sr.DirectorJun 13Buy24.404,00097,60021,882Jun 27 03:40 PM
PAPA JOSEPH CCHAIRMAN & CEOJun 10Buy24.48202,0004,944,9602,442,199Jun 13 06:47 AM
LYB LyondellBasell Industries N.V. daily Stock Chart
LYB [NYSE]
LyondellBasell Industries N.V.
IndexS&P 500 P/E9.25 EPS (ttm)8.73 Insider Own0.20% Shs Outstand402.51M Perf Week-0.46%
Market Cap32.49B Forward P/E8.71 EPS next Y9.27 Insider Trans-85.15% Shs Float324.28M Perf Month-7.65%
Income3.62B PEG- EPS next Q2.73 Inst Own76.60% Short Float3.09% Perf Quarter-11.61%
Sales30.87B P/S1.05 EPS this Y-4.70% Inst Trans0.29% Short Ratio3.66 Perf Half Y-6.82%
Book/sh16.03 P/B5.04 EPS next Y-6.06% ROA15.30% Target Price95.00 Perf Year-0.79%
Cash/sh4.13 P/C19.56 EPS next 5Y-2.78% ROE57.90% 52W Range69.82 - 97.64 Perf YTD-5.89%
Dividend3.40 P/FCF23.55 EPS past 5Y16.00% ROI24.60% 52W High-17.32% Beta1.03
Dividend %4.21% Quick Ratio1.30 Sales past 5Y-9.50% Gross Margin19.00% 52W Low15.63% ATR1.74
Employees13000 Current Ratio2.20 Sales Q/Q25.00% Oper. Margin15.90% RSI (14)40.49 Volatility1.97% 2.07%
OptionableYes Debt/Eq1.40 EPS Q/Q-15.90% Profit Margin11.70% Rel Volume0.67 Prev Close80.67
ShortableYes LT Debt/Eq1.30 EarningsApr 28 BMO Payout39.10% Avg Volume2.73M Price80.73
Recom2.70 SMA20-1.41% SMA50-5.78% SMA200-5.24% Volume1,841,670 Change0.07%
May-08-17Downgrade BofA/Merrill Buy → Underperform
Feb-10-17Downgrade Susquehanna Positive → Neutral
Feb-06-17Reiterated RBC Capital Mkts Sector Perform $92 → $95
Dec-29-16Reiterated Cowen Market Perform $87 → $90
Oct-14-16Initiated Tudor Pickering Buy
Sep-13-16Reiterated Deutsche Bank Hold $80 → $83
Jun-27-16Downgrade RBC Capital Mkts Outperform → Sector Perform $100 → $84
Jun-23-16Downgrade JP Morgan Overweight → Neutral $100 → $80
Jun-13-16Downgrade Cowen Outperform → Market Perform $105 → $87
Apr-27-16Downgrade Nomura Buy → Neutral
Apr-05-16Downgrade Atlantic Equities Neutral → Underweight
Feb-03-16Downgrade RBC Capital Mkts Top Pick → Outperform $105 → $95
Jan-11-16Downgrade Credit Agricole Outperform → Underperform
Nov-25-15Reiterated Cowen Outperform $98 → $105
Oct-12-15Downgrade Macquarie Outperform → Neutral
Sep-17-15Reiterated Deutsche Bank Hold $100 → $95
Sep-11-15Initiated Bernstein Outperform $110
Sep-01-15Reiterated Cowen Outperform $115 → $98
May-08-15Initiated Standpoint Research Buy
Apr-28-15Reiterated RBC Capital Mkts Top Pick $111 → $123
May-29-17 03:55AM  LyondellBasell (LYB) Down 7.7% Since Earnings Report: Can It Rebound? Zacks
May-26-17 05:22PM  LyondellBasell Pleases Investors with Dividend Increase Market Realist
May-24-17 06:45AM  LyondellBasell Announces Increase to Quarterly Dividend and Shareholder Approval of New Share Repurchase Program PR Newswire
May-23-17 09:00AM  LyondellBasell to Address Bernstein 33rd Annual Strategic Decisions Conference PR Newswire
May-22-17 05:39PM  LyondellBasell to Build Hyperzone Polyethylene Plant Market Realist
12:42PM  LyondellBasell Receives Five Top Safety Awards PR Newswire
May-16-17 04:10PM  LyondellBasell starts construction on Gulf Coast plant using new technology American City Business Journals
03:12PM  LyondellBasell to Address Barclays Americas Select Franchise Conference 2017 PR Newswire
09:22AM  LyondellBasell Starts Construction of New Plant at La Porte Zacks
May-15-17 05:01PM  LyondellBasell Begins Construction of Hyperzone PE Plant at its La Porte Complex PR Newswire
04:03PM  ETFs with exposure to LyondellBasell Industries NV : May 15, 2017 Capital Cube
May-08-17 10:21AM  Material ETFs Rise on Solid Q1 Earnings Zacks
09:07AM  Top Analyst Upgrades and Downgrades: Asure Software, Fluor, Lam Research, Newfield Exploration, Tesla, Yext and Many More 24/7 Wall St.
May-04-17 04:08PM  ETFs with exposure to LyondellBasell Industries NV : May 4, 2017 Capital Cube
May-03-17 10:11AM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017 Capital Cube
10:03AM  LyondellBasell Among Top Donors to United Way of Greater Houston Campaign for 2016 PR Newswire
May-02-17 01:00PM  [$$] Chemical industry split about the case for more US plants Financial Times
10:36AM  Dow Chemicals Latest Valuations Post 1Q17 Earnings Market Realist
08:20AM  Edited Transcript of LYB earnings conference call or presentation 28-Apr-17 3:00pm GMT Thomson Reuters StreetEvents
Apr-28-17 03:31PM  LyondellBasell (LYB) Misses Q1 Earnings Estimates, Sales Top Zacks
07:55AM  LyondellBasell (LYB) Q1 Earnings Miss Estimates, Sales Beat Zacks
06:56AM  LyondellBasell misses 1Q profit forecasts Associated Press
06:45AM  LyondellBasell Reports First-Quarter 2017 Earnings PR Newswire
Apr-26-17 04:50PM  LyondellBasell (LYB) Q1 Earnings: What's in the Cards? Zacks
Apr-21-17 08:28PM  [$$] Judge Dismisses Most of Lyondell Bankruptcy Lawsuit The Wall Street Journal
08:27PM  [$$] Blavatnik cleared of fraud claims over Lyondell Chemical buyout Financial Times
10:50AM  What's in Store for Material ETFs in Q1 Earnings? Zacks
09:06AM  What Are Dow Chemicals Valuations ahead of 1Q17 Earnings? Market Realist
Apr-20-17 09:07AM  Why DuPont Trades at a Premium to Its Peers Market Realist
Apr-17-17 09:49AM  LyondellBasells ACP Polyethylene Technology to Be Used by Hengli Market Realist
Apr-14-17 11:30AM  LyondellBasell to Discuss First-Quarter Results on Friday, April 28, 2017 PR Newswire
Apr-05-17 09:29AM  Opening Bell, April 5, 2107 CNBC Videos
09:29AM  Opening Bell, April 5, 2107
Apr-03-17 11:20AM  LyondellBasell Industries NV : LYB-US: Dividend Analysis : March 06th, 2017 (record date) : By the numbers : April 3, 2017 Capital Cube
11:20AM  LyondellBasell Industries NV : LYB-US: Dividend Analysis : March 06th, 2017 (record date) : By the numbers : April 3, 2017
09:55AM  LyondellBasell Joins the Astros Foundation Community Leaders Program PR Newswire
Mar-31-17 08:55AM  See which Houston brands rank among the 500 most valuable in the U.S. this year at bizjournals.com
Mar-30-17 09:30AM  Zacks Industry Outlook Highlights: Dow Chemical, DuPont, PPG Industries, Celanese and LyondellBasell Industries Investopedia
09:30AM  Zacks Industry Outlook Highlights: Dow Chemical, DuPont, PPG Industries, Celanese and LyondellBasell Industries
09:07AM  Inside Eastman Chemicals Latest Valuations Market Realist
09:07AM  Inside Eastman Chemicals Latest Valuations
Mar-29-17 03:46PM  Chemicals Industry Stock Outlook - March 2017 Investopedia
03:46PM  Chemicals Industry Stock Outlook - March 2017
01:04PM  LyondellBasell to Host Investor Day 2017 on April 5, 2017 PR Newswire
10:00AM  Is LyondellBasell (LYB) a Great Stock for Value Investors? Zacks
10:00AM  Is LyondellBasell (LYB) a Great Stock for Value Investors?
10:00AM  Is LyondellBasell (LYB) a Great Stock for Value Investors? at Investopedia
Mar-23-17 07:37AM  Dow Chemical Trades at a Premium to Its Peers Market Realist
07:37AM  Dow Chemical Trades at a Premium to Its Peers
Mar-22-17 12:35PM  Dow Chemical Provides a Stable Dividend Yield
10:51AM  Dow Chemical Will Pay a Dividend of $0.46 in 1Q17
10:50AM  Analyzing How Dow Chemical Stock Has Performed in 2017
Mar-20-17 10:05AM  Shandong Yuhuang Shengshi Chemical Finalizes Deal with LYB
09:07AM  What Huntsmans Inconsistent Dividend Means to Investors
Mar-13-17 09:07AM  Can LyondellBasells Valuation Come Out of Its Peers Shadow?
07:37AM  LyondellBasell Gets Hold Rating from Majority of Analysts
Mar-10-17 01:05PM  How Attractive Is LyondellBasells Dividend Yield?
11:35AM  LyondellBasell Gears Up to Pay Its First Dividend in 2017
09:48AM  LyondellBasell Stock: 2017 Performance So Far
09:00AM  LyondellBasell Honored by Junior Achievement with US President's Volunteer Service Award PR Newswire
07:35AM  LyondellBasell (LYB) Poised on Expansion Amid Challenges
Mar-09-17 12:46PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an
Mar-07-17 11:35AM  LyondellBasells Interest Expenses Set to Fall Further
10:05AM  What LyondellBasells Debt-to-Equity Ratio Indicates
08:20AM  LyondellBasell Issued $1 Billion of Guaranteed Notes
Feb-28-17 01:06PM  LyondellBasell Prices $1 Billion in Public Offering Guaranteed Notes
Feb-27-17 09:07AM  Why DuPont Is Trading at a Premium Compared to Its Peers
Feb-23-17 05:26PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:04PM  LYONDELLBASELL INDUSTRIES N.V. Financials
Feb-21-17 05:51PM  LyondellBasell Prices Public Offering of Guaranteed Notes PR Newswire
10:33AM  LYB International Finance II B.V. -- Moody's rates LyondellBasell's new notes Baa1, outlook stable at Moody's
Feb-17-17 01:05PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 10-K, Annual Report
06:45AM  LyondellBasell Board Authorizes Interim Dividend PR Newswire
Feb-14-17 08:15AM  Post Earnings Coverage as LyondellBasell's Q4 Top-line Beat Market Estimates Accesswire
Feb-08-17 09:06AM  How Are Analysts Viewing LyondellBasell after 4Q16 Earnings?
07:36AM  Why LyondellBasells Refining Segment Revenues Rose in 4Q16
Feb-07-17 02:19PM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: 2016 By the Numbers : February 7, 2017
10:40AM  Why Did LYBs Intermediates and Derivatives Segments Revenue Rise?
09:07AM  How Did LYBs EAI Olefins and Polyolefins Segment Perform in 4Q16?
07:36AM  How Did LYBs Olefins and Polyolefins Americas Segment Fare?
Feb-06-17 05:35PM  LyondellBasells 4Q16 Adjusted Earnings Beat Estimates
03:47PM  LyondellBasell Stock Rose after 4Q16 Revenue Beat Estimates
10:59AM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017
Feb-03-17 04:40PM  Edited Transcript of LYB earnings conference call or presentation 3-Feb-17 4:00pm GMT
02:56PM  LyondellBasell's (LYB) Q4 Earnings, Revenues Top Estimates
08:39AM  LyondellBasell (LYB) Q4 Earnings, Sales Beat Estimates
07:16AM  LyondellBasell tops Street 4Q forecasts
07:07AM  Q4 2016 LyondellBasell Industries NV Earnings Release - Before Market Open
06:45AM  LyondellBasell Reports 2016 Earnings PR Newswire
Feb-02-17 08:34AM  Should You Sell LyondellBasell Industries (LYB) Before Earnings?
06:59AM  FMC Corp (FMC) Q4 Earnings: What's in Store for the Stock?
Feb-01-17 01:30PM  Here's How Valero's Management Thinks Trump's Policies Will Impact the Business at Motley Fool
08:50AM  LyondellBasell (LYB) Q4 Earnings: What's in the Cards?
Jan-30-17 09:30AM  Zacks.com featured highlights: OraSure Technologies, Union Pacific, LyondellBasell Industries, Advanced Energy Industries and Rollins
Jan-27-17 08:32AM  5 Efficient Stocks Potent Enough to Boost Your Returns
Jan-26-17 09:30AM  Zacks Investment Ideas feature highlights: Abb, Applied Materials, Broadcom, LyondellBassel and Union Pacific
09:06AM  Why LyondellBasell Is Trading at a Discount Compared to Peers
07:37AM  Why Most Analysts Recommend a Hold for LyondellBasell
Jan-25-17 02:05PM  Why Analysts Expect 21% Rise in LyondellBasells EPS
12:36PM  Why Analysts Expect LyondellBasells Revenue to Rise in 4Q16
LyondellBasell Industries N.V. operates as a manufacturer of chemicals and polymers, refiner of crude oil, producer of gasoline blending components, and developer and licensor of technologies for production of polymers worldwide. The company operates in five segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Refining; and Technology. It produces and markets olefins, including ethylene, propylene, and butadiene; polyethylene products, which consist of high density polyethylene, low density polyethylene, and linear low density polyethylene; polyolefins, such as polyethylene and polypropylene (PP); and PP homopolymers, copolymers, and compounds. The company also produces and sells propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomers, methanol products, glacial acetic acids, vinyl acetate monomers, and ethylene oxides and derivatives. In addition, it refines crude oil into gasoline, diesel, and jet fuel; develops and licenses chemical and polyolefin process technologies; and manufactures and sells polyolefin catalysts, as well as purchases and sells ethylene. The company also exports its products. LyondellBasell Industries N.V. was founded in 2005 and is based in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roudeix RichardSVP, O&P - EAIMay 01Option Exercise40.002329,2805,086May 03 03:29 PM
AI New Holdings 2 LLC10% OwnerMar 09Sale89.12139,61712,441,96972,772Mar 10 04:12 PM
AI New Holdings 2 LLC10% OwnerMar 02Sale93.5039,4253,686,23872,912Mar 03 04:48 PM
AI New Holdings 2 LLC10% OwnerMar 01Sale94.32206,78719,504,43972,951Mar 03 04:48 PM
Wolf Jacquelyn HSVP, Human ResourcesFeb 22Option Exercise78.2714,7691,155,95931,283Feb 22 08:13 PM
Wolf Jacquelyn HSVP, Human ResourcesFeb 22Sale94.0114,7691,388,41616,514Feb 22 08:13 PM
AI New Holdings 2 LLC10% OwnerFeb 22Sale94.5514,1711,339,85873,157Feb 24 04:04 PM
AI New Holdings 2 LLC10% OwnerFeb 13Sale92.24862,20579,532,80773,171Feb 14 05:51 PM
AI New Holdings 2 LLC10% OwnerFeb 10Sale92.45305,70028,261,84374,030Feb 14 05:51 PM
AI New Holdings 2 LLC10% OwnerFeb 09Sale92.29900,00083,056,95074,334Feb 09 06:11 PM
AI New Holdings 2 LLC10% OwnerFeb 08Sale91.591,132,095103,689,48775,231Feb 09 06:11 PM
AI New Holdings 2 LLC10% OwnerFeb 07Sale93.021,000,00093,018,14776,359Feb 09 06:11 PM
Bindra Jagjeet S.DirectorAug 30Sale80.013,750300,0208,876Sep 01 09:17 AM
TMO Thermo Fisher Scientific Inc. daily Stock Chart
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E31.60 EPS (ttm)5.49 Insider Own0.20% Shs Outstand391.00M Perf Week1.10%
Market Cap67.81B Forward P/E17.03 EPS next Y10.18 Insider Trans-7.42% Shs Float390.49M Perf Month4.03%
Income2.17B PEG2.97 EPS next Q2.26 Inst Own89.50% Short Float0.93% Perf Quarter9.43%
Sales18.74B P/S3.62 EPS this Y3.50% Inst Trans-0.53% Short Ratio2.30 Perf Half Y20.84%
Book/sh55.74 P/B3.11 EPS next Y10.48% ROA4.80% Target Price185.41 Perf Year14.70%
Cash/sh1.85 P/C93.54 EPS next 5Y10.65% ROE10.10% 52W Range139.07 - 173.64 Perf YTD22.91%
Dividend0.60 P/FCF28.14 EPS past 5Y13.90% ROI6.40% 52W High-0.13% Beta1.06
Dividend %0.35% Quick Ratio0.90 Sales past 5Y9.60% Gross Margin45.90% 52W Low24.70% ATR1.92
Employees55000 Current Ratio1.40 Sales Q/Q10.90% Oper. Margin13.60% RSI (14)73.89 Volatility0.75% 1.01%
OptionableYes Debt/Eq0.78 EPS Q/Q38.70% Profit Margin11.60% Rel Volume0.43 Prev Close172.90
ShortableYes LT Debt/Eq0.70 EarningsApr 26 BMO Payout10.90% Avg Volume1.58M Price173.42
Recom1.70 SMA201.63% SMA507.38% SMA20013.20% Volume682,524 Change0.30%
May-19-17Initiated Cantor Fitzgerald Overweight $194
May-09-17Reiterated Barclays Overweight $175 → $190
Jan-18-17Initiated Deutsche Bank Buy $163
Nov-10-16Resumed Leerink Partners Outperform
Sep-22-16Resumed JP Morgan Overweight $180
Sep-09-16Downgrade Cleveland Research Buy → Neutral
May-27-16Reiterated Mizuho Buy $166 → $170
May-19-16Reiterated Mizuho Buy $163 → $166
May-03-16Reiterated Mizuho Buy $160 → $163
Apr-29-16Downgrade Jefferies Buy → Hold
Apr-04-16Reiterated Mizuho Buy $150 → $160
Mar-02-16Reiterated Topeka Capital Markets Buy $145 → $155
Jan-11-16Reiterated Stifel Buy $150 → $158
Jan-07-16Initiated Deutsche Bank Buy $160
Oct-06-15Initiated Argus Buy $145
Jul-23-15Reiterated Mizuho Buy $150 → $160
May-21-15Reiterated Barclays Overweight $160 → $165
Mar-10-15Initiated UBS Buy $160
Jan-21-15Reiterated Robert W. Baird Outperform $142 → $144
Aug-12-14Initiated Stifel Buy $150
May-26-17 07:37AM  St. Jude Medical May Establish ABT as a Key Medical Device Player Market Realist
May-25-17 03:54PM  Analysts Recommendations for Abbott Laboratories in May 2017 Market Realist
May-19-17 07:16PM  Phononic CEO shares the key to his company's market penet... CNBC Videos
10:19AM  Thermo Fisher Initiated With 'Overweight' Rating at Cantor Fitzgerald TheStreet.com
May-18-17 02:23PM  Royal DSM N.V. -- Moody's changes Royal DSM's outlook to stable from negative; affirms A3/P-2 ratings Moody's
08:30AM  Thermo Fisher Scientific Declares Quarterly Dividend PR Newswire
May-17-17 03:46PM  Patheon Holdings I B.V. -- Moody's places ratings of Patheon Holdings I B.V. on review for upgrade Moody's
May-16-17 12:23PM  Thermo Fisher Scientific (Finance I) B.V. -- Moody's affirms Thermo Fisher Scientific's Baa2 senior unsecured rating following Patheon acquisition announcement Moody's
10:12AM  Company News for May 16, 2017 Zacks
08:33AM  Thermo Fisher (TMO) to Buy Patheon, Expand in Biopharma Zacks
08:15AM  Blog Coverage: Thermo Fisher to Acquire Patheon; Expects to Realize Multiple Synergies from the Transaction Accesswire
May-15-17 04:11PM  Thermo Fisher Scientific: A Growth Story (TMO) Investopedia
04:07PM  Patheon Stock Spikes After Being Purchased by Thermo Fisher for $7.2 Billion TheStreet.com
01:31PM  [$$] Thermo Fisher to Buy Patheon for $5.2 Billion The Wall Street Journal
01:26PM  Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services Reuters
12:47PM  Some of Wall Street's biggest firms just landed a big pay day Business Insider
11:58AM  Did Pantheon Get Enough in Its Buyout? 24/7 Wall St.
11:19AM  US STOCKS-S&P 500, Nasdaq Composite hit record-highs Reuters
11:05AM  Why Patheon N.V. Is Soaring Today Motley Fool
10:55AM  Thermo Fisher buys Patheon Reuters Videos
10:40AM  Waltham's Thermo Fisher buys drug ingredients maker for $5.2B American City Business Journals
10:03AM  Story Stocks from Briefing.com Briefing.com
08:43AM  DSM to tender Patheon stake to Thermo Fisher Reuters
07:53AM  Thermo Fisher buying Patheon for $5.2 billion Associated Press
07:45AM  Thermo Fischer to Buy Patheon in $7.2 Billion Deal Bloomberg Video
07:37AM  Stock Futures Mostly Higher as Russia, Saudi Arabia Call for OPEC Deal Extension TheStreet.com
07:34AM  Thermo Fisher to buy Patheon for about $5.2 bln Reuters
07:27AM  Thermo Fisher Scientific is buying drug-ingredients maker Patheon for $7.2 billion Business Insider
07:20AM  5 Things You Must Know Before the Market Opens Monday TheStreet.com
07:19AM  Thermo Fisher to acquire Patheon in deal valued at $7.2 billion, including $2 billion net debt MarketWatch
07:18AM  DSM Informs Market on Patheon N.V. PR Newswire
07:14AM  Thermo Fisher to buy Patheon for about $5.2 bln Reuters
07:14AM  Thermo Fisher to buy Patheon in $5.2 billion deal CNBC
07:00AM  Thermo Fisher Scientific to Acquire Patheon, a Leading Contract Development and Manufacturing Organization (CDMO) PR Newswire
12:03AM  Thermo Fisher in talks to buy Patheon: Bloomberg Reuters
May-14-17 11:45PM  Thermo Fisher in talks to buy Patheon - Bloomberg Reuters
10:49PM  Thermo Fisher Said in Talks to Buy Drug Ingredient Maker Patheon Bloomberg
10:49PM  Thermo Fisher Extends Buying Binge With Talks to Acquire Patheon Bloomberg
May-09-17 06:48PM  Cramer's lightning round: This telecom's quarter was less than impressive CNBC
07:30AM  Cramer: These Sectors Look Bullish (Part III) TheStreet.com
May-08-17 11:20AM  How to Get on Board Thermo Fisher Scientific TheStreet.com
May-05-17 10:35AM  3 Sexy Stocks And One For Downside Protection Forbes
08:00AM  Thermo Fisher Scientific to Host Analyst Meeting PR Newswire
May-01-17 08:15AM  Post Earnings Coverage as Thermo Fisher's Quarterly Revenue Grew 11%; GAAP EPS Surged 39% Accesswire
Apr-27-17 09:41PM  Edited Transcript of TMO earnings conference call or presentation 26-Apr-17 12:30pm GMT Thomson Reuters StreetEvents
Apr-26-17 05:27PM  Edwards Lifesciencse and Deckers rise; US Steel plunges Associated Press +5.79%
04:41PM  Thermo Fisher Scientific, Inc. Value Analysis (NYSE:TMO) : April 26, 2017 Capital Cube
04:19PM  GLOBAL MARKETS-Stocks retreat after Trump tax plan; Canada dollar, Mexico peso weaken Reuters
01:50PM  GLOBAL MARKETS-Stocks advance on earnings; Canada dollar, Mexico peso weaken on NAFTA news Reuters
10:46AM  Thermo Fisher (TMO) Tops Q1 Earnings, Sales, Raises Guidance Zacks
07:53AM  Thermo Fisher (TMO) Beats on Q1 Earnings & Sales Estimates Zacks
06:21AM  Thermo Fisher tops profit estimate, ups forecast Reuters
06:14AM  Thermo Fisher beats Street 1Q forecasts Associated Press
06:00AM  Thermo Fisher Scientific Reports First Quarter 2017 Results PR Newswire
Apr-25-17 09:03AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : April 25, 2017 Capital Cube
Apr-21-17 07:05AM  Thermo Fisher (TMO) Up 4.5% Since Earnings Report: Can It Continue? Zacks
Apr-20-17 04:20PM  The Top Gene-Sequencing Stock to Buy in 2017 Motley Fool
10:01AM  Will Thermo Fisher (TMO) Pull a Surprise in Q1 Earnings? Zacks
Apr-18-17 06:00AM  New X-ray Machine Handles Heavy Products in Washdown Environments PR Newswire
Apr-05-17 05:35PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : April 5, 2017 Capital Cube
11:18AM  Thermo Fisher Scientific, Inc. : TMO-US: Dividend Analysis : March 15th, 2017 (record date) : By the numbers : April 5, 2017 Capital Cube
Apr-04-17 02:48PM  Thermo Fisher CEO got $59M in compensation, stock value in 2016 American City Business Journals
Mar-31-17 08:30AM  Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 26, 2017 Business Wire
Mar-30-17 08:27AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bearish Manner : TMO-US : March 30, 2017 Capital Cube
Mar-24-17 07:00AM  Exxon, Thermo Fisher and 2 More Are Showing Red Flags TheStreet.com
Mar-23-17 09:38AM  Should Value Investors Consider Thermo Fisher (TMO) Stock? Zacks
Mar-22-17 05:56PM  MedTech Long-Term Prospects Impress: Which Stocks to Buy? Zacks
04:50PM  [$$] GTCR Sells Cole-Parmer Instrument to Golden Gate The Wall Street Journal
Mar-17-17 04:05PM  Thermo Fisher Poised on Innovation, Global Growth Amid Woes Zacks
Mar-16-17 11:37AM  Thermo Fisher Scientific, Inc. :TMO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017
06:58AM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an
Mar-10-17 01:40PM  Thermo Fisher Scientific, Inc. :TMO-US: Earnings Analysis: 2016 By the Numbers : March 10, 2017
Mar-08-17 04:45PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mar-07-17 05:05PM  Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes Business Wire
08:00AM  Thermo Fisher Scientific to Present at the Barclays Global Healthcare Conference on March 14, 2017 Business Wire
07:44AM  Corporates launch funding frenzy in busiest day of year Reuters
Mar-06-17 09:00AM  Thermo Fisher Scientific Showcases Integrated Analytical Workflows During Pittcon 2017 Business Wire
08:48AM  Thermo Fisher Scientific Looks to Enhance Informatics Solutions with Acquisition
Mar-04-17 01:04PM  THERMO FISHER SCIENTIFIC INC. Financials
Mar-02-17 09:26AM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles o
Mar-01-17 09:00AM  Thermo Fisher Scientific Elects New Director to Board Business Wire
Feb-28-17 06:46PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 10-K, Annual Report
04:15PM  Thermo Fisher Scientific Declares Quarterly Dividend Business Wire
Feb-26-17 09:25PM  Two Mass. companies involved in some of the biggest tech M&A deals of 2016 at bizjournals.com
Feb-24-17 09:11AM  Patent Damages In The Global Supply Chain at Forbes
Feb-22-17 01:10PM  Thermo Fisher unit prevails in Supreme Court patent case at bizjournals.com
10:25AM  Thermo Fisher Comes Out on Top in Promega Patent Case
10:13AM  Thermo Fisher did not infringe genetic-testing patent, U.S. top court says Reuters
10:11AM  Thermo Fisher Backed by Supreme Court in Promega Patent Case
10:11AM  Patent Royalties Curbed as Supreme Court Backs Thermo Fisher
Feb-14-17 06:15PM  Thermo Fisher Scientific Completes Acquisition of Finesse Solutions, Inc. Business Wire
Feb-13-17 09:15AM  Thermo Fisher Scientific Receives Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Finesse Solutions, Inc. Business Wire
Feb-08-17 04:53PM  Better Buy: Illumina, Inc. vs. Thermo Fisher Scientific at Motley Fool
Feb-07-17 08:57AM  Weitz Investment Looks to Visa (V), Amazon (AMZN), Others for Big Returns After Subpar 2016 at Insider Monkey
Feb-02-17 03:10PM  Why the state's two biggest medical device firms have gained $4.5B in market cap this week at bizjournals.com
09:30AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, PayPal, Thermo Fisher, Celgene and American Airlines
Feb-01-17 05:59PM  Final Trade: DIS, GOOGL & more
03:17PM  Top Research Reports for February 1, 2017
Jan-31-17 06:30PM  Why Momenta Pharmaceuticals, Ally Financial, and Thermo Fisher Scientific Jumped Today at Motley Fool +6.35%
04:55PM  The Hot Stock: Thermo Fisher Scientific Jumps 6.4% at Barrons.com
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems to support clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers controlled temperature technology products; sample preparation and preservation equipment; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; and research and safety market channel, and biopharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shine Daniel PSenior Vice PresidentMay 24Option Exercise65.154,688305,42329,200May 25 05:29 PM
Shine Daniel PSenior Vice PresidentMay 24Sale171.884,688805,75024,512May 25 05:29 PM
Loewald Thomas WSenior Vice PresidentApr 27Sale168.761,532258,54041,277Apr 28 05:00 PM
WILVER PETER MExec. VP & Chief Admin OfficerMar 15Sale160.739,0791,459,26862,517Mar 16 05:11 PM
CASPER MARC NChief Executive OfficerMar 15Sale158.6020,0003,172,000289,279Mar 16 05:07 PM
WILVER PETER MExec. VP & Chief Admin OfficerMar 10Option Exercise126.229,9871,260,56081,583Mar 13 05:14 PM
WILVER PETER MExec. VP & Chief Admin OfficerMar 10Sale158.189,9871,579,74471,596Mar 13 05:14 PM
Loewald Thomas WSenior Vice PresidentMar 08Option Exercise73.247,675562,11750,484Mar 09 04:13 PM
Loewald Thomas WSenior Vice PresidentMar 08Sale157.397,6751,207,96842,809Mar 09 04:13 PM
Williamson StephenSr. VP and CFOMar 06Sale158.712,500396,77540,290Mar 08 05:15 PM
Loewald Thomas WSenior Vice PresidentMar 06Sale158.714,049642,61742,809Mar 08 05:12 PM
HOOGASIAN SETH HSr. VP and Gen. CounselMar 06Sale158.713,142498,66731,104Mar 08 05:10 PM
CASPER MARC NChief Executive OfficerSep 02Option Exercise54.9728,7971,582,971307,444Sep 06 04:52 PM
CASPER MARC NChief Executive OfficerSep 02Sale151.0128,7974,348,635278,647Sep 06 04:52 PM
CASPER MARC NChief Executive OfficerSep 01Option Exercise54.9730,0001,649,100308,647Sep 02 05:32 PM
CASPER MARC NChief Executive OfficerSep 01Sale151.1730,0004,535,076278,647Sep 02 05:32 PM
Shine Daniel PSenior Vice PresidentAug 29Sale152.281,699258,72417,437Aug 31 05:00 PM
Loewald Thomas WSenior Vice PresidentAug 29Sale152.283,256495,82435,814Aug 31 04:58 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Aug 29Sale152.282,270345,67627,384Aug 31 04:56 PM
Shine Daniel PSenior Vice PresidentAug 26Sale151.7847672,24719,136Aug 30 05:20 PM
Loewald Thomas WSenior Vice PresidentAug 26Sale151.92913138,70339,070Aug 30 05:17 PM
CASPER MARC NChief Executive OfficerAug 15Sale155.9625,0003,899,031295,998Aug 17 04:54 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Aug 10Sale156.005,023783,58831,914Aug 11 04:46 PM
HARRIS C MARTINDirectorAug 05Sale157.3339061,3594,648Aug 08 04:53 PM
Loewald Thomas WSenior Vice PresidentJul 13Option Exercise73.248,025587,75152,194Jul 14 04:35 PM
Loewald Thomas WSenior Vice PresidentJul 13Sale155.008,0251,243,87544,169Jul 14 04:35 PM
CASPER MARC NChief Executive OfficerJul 05Option Exercise54.9720,0001,099,400340,998Jul 07 04:42 PM
CASPER MARC NChief Executive OfficerJul 05Sale147.6920,0002,953,804320,998Jul 07 04:42 PM
CASPER MARC NChief Executive OfficerJul 01Option Exercise54.9730,0001,649,100350,998Jul 06 04:42 PM
CASPER MARC NChief Executive OfficerJul 01Sale148.8530,0004,465,638320,998Jul 06 04:42 PM
Shine Daniel PSenior Vice PresidentJun 15Option Exercise54.976,900379,29328,779Jun 16 05:00 PM
Shine Daniel PSenior Vice PresidentJun 15Sale148.316,9001,023,35621,879Jun 16 05:00 PM
WILVER PETER MExec. VP & Chief Admin OfficerJun 10Option Exercise54.9768,2003,748,954138,777Jun 14 04:47 PM
WILVER PETER MExec. VP & Chief Admin OfficerJun 10Sale152.3868,20010,392,63370,577Jun 14 04:47 PM
MANZI JIM PDirectorJun 03Sale153.001,137173,96138,733Jun 06 04:41 PM
Loewald Thomas WSenior Vice PresidentJun 02Option Exercise73.2415,0001,098,60059,169Jun 06 04:39 PM
Loewald Thomas WSenior Vice PresidentJun 02Sale152.8415,0002,292,60044,169Jun 06 04:39 PM
CRM Salesforce.com, inc. daily Stock Chart
CRM [NYSE]
Salesforce.com, inc.
IndexS&P 500 P/E478.05 EPS (ttm)0.19 Insider Own0.10% Shs Outstand715.65M Perf Week3.92%
Market Cap65.00B Forward P/E53.94 EPS next Y1.68 Insider Trans-75.02% Shs Float675.24M Perf Month5.80%
Income131.70M PEG16.87 EPS next Q0.32 Inst Own87.20% Short Float2.20% Perf Quarter11.39%
Sales8.86B P/S7.33 EPS this Y457.90% Inst Trans1.93% Short Ratio3.28 Perf Half Y22.83%
Book/sh11.24 P/B8.08 EPS next Y29.54% ROA0.80% Target Price102.53 Perf Year8.97%
Cash/sh4.50 P/C20.19 EPS next 5Y28.34% ROE1.90% 52W Range66.43 - 91.81 Perf YTD32.68%
Dividend- P/FCF36.04 EPS past 5Y69.50% ROI2.10% 52W High-1.07% Beta1.24
Dividend %- Quick Ratio0.70 Sales past 5Y29.90% Gross Margin73.10% 52W Low36.73% ATR1.36
Employees25000 Current Ratio0.70 Sales Q/Q24.60% Oper. Margin0.00% RSI (14)69.04 Volatility1.63% 1.46%
OptionableYes Debt/Eq0.32 EPS Q/Q-123.10% Profit Margin1.50% Rel Volume1.17 Prev Close91.27
ShortableYes LT Debt/Eq0.18 EarningsMay 18 AMC Payout0.00% Avg Volume4.53M Price90.83
Recom1.80 SMA203.29% SMA506.62% SMA20016.45% Volume5,275,627 Change-0.48%
May-19-17Reiterated Stifel Buy $100 → $105
May-15-17Reiterated The Benchmark Company Buy $100 → $110
May-15-17Reiterated BMO Capital Markets Outperform $92 → $100
Apr-27-17Initiated Credit Suisse Outperform $110
Mar-01-17Reiterated Wedbush Outperform $98 → $102
Feb-28-17Resumed Robert W. Baird Outperform $90
Feb-16-17Initiated Needham Hold
Jan-12-17Downgrade Pivotal Research Group Buy → Hold $105 → $76
Jan-11-17Initiated Wells Fargo Outperform
Nov-18-16Reiterated Wedbush Outperform $96 → $98
Nov-18-16Reiterated Mizuho Buy $85 → $95
Nov-18-16Reiterated BMO Capital Markets Outperform $86 → $90
Oct-18-16Initiated Rosenblatt Buy $90
Sep-01-16Reiterated Wedbush Outperform $98 → $96
Sep-01-16Reiterated RBC Capital Mkts Outperform $91 → $85
Sep-01-16Reiterated Mizuho Buy $100 → $85
Sep-01-16Reiterated BMO Capital Markets Outperform $98 → $86
Jun-15-16Initiated BMO Capital Markets Outperform $98
May-19-16Reiterated Wunderlich Buy $93 → $101
May-19-16Reiterated Wedbush Outperform $95 → $98
May-26-17 09:06AM  How Analysts View Salesforce Stock: 91% Recommend a Buy Market Realist
07:35AM  Salesforces EV-to-EBITDA Multiple Compared to Its Peers Market Realist
May-25-17 01:55PM  Exclusive: Salesforce, WeWork in talks for big leases at Salesforce Tower American City Business Journals
12:37PM  ETFs with exposure to salesforce.com, inc. : May 25, 2017 Capital Cube
10:35AM  Salesforces Value Proposition in the Software Space Market Realist
09:07AM  What T-Mobile Stands to Gain from Green Energy Investments Market Realist
09:06AM  A Look into Salesforces Technical Indicators Market Realist
07:35AM  How Salesforce Became a Leader in Enterprise High Productivity Space Market Realist
May-24-17 05:00PM  Salesforce, Dell Technologies Reach Strategic Agreement TheStreet.com
04:47PM  Salesforce and Dell announce strategic agreement CNBC Videos
04:05PM  Salesforce Announces Strategic Agreement with Dell Technologies PR Newswire
12:41PM  Earnings Calendar, Analyst Estimates And Stocks To Watch Investor's Business Daily
10:36AM  Why Salesforce Is a Distinct Investment Option in the SaaS Space Market Realist
10:30AM  salesforce.com, inc. :CRM-US: Earnings Analysis: Q1, 2018 By the Numbers : May 24, 2017 Capital Cube
09:06AM  Salesforce Beats Estimates: Can Its Good Run Continue? Market Realist
09:05AM  Why Third Point Increased Its Position in Salesforce Market Realist
08:00AM  Salesforce Chairman and CEO Marc Benioff to Speak at Upcoming Events PR Newswire
07:36AM  Salesforces Short-Term Outlook Unveiled Market Realist
07:35AM  Chart in Focus: Salesforces Cash Flow in 2017 Market Realist
May-23-17 04:30PM  Salesforce Announces Annual Stockholders Meeting to be Held in San Francisco on Tuesday, June 6, 2017 PR Newswire
03:10PM  Edited Transcript of CRM earnings conference call or presentation 18-May-17 9:00pm GMT Thomson Reuters StreetEvents
02:36PM  Salesforces Fiscal 1Q18 Results: 3 Key Takeaways Market Realist
12:43PM  Salesforce vs. Oracle: Which Stock Is The Better Buy? Zacks
12:18PM  Salesforce.com Delivers 25% Revenue Growth Motley Fool
11:15AM  Which Stocks Are Showing Rising Relative Strength? Investor's Business Daily
11:11AM  Cloud-Based Software Leader Salesforce.com Earns Stock Rating Upgrade Investor's Business Daily
10:36AM  Salesforce and Its Peers: Profitability in the SaaS Space Market Realist
09:47AM  Salesforce.com Could Trade Sideways Before Renewed Gains TheStreet.com
09:06AM  Assessing Salesforce as an Investment in 2017 Market Realist
07:36AM  How the US Dollar Could Contribute to Salesforces Revenue Growth Market Realist
May-22-17 07:01PM  Cramer: Get Your Head Into the Cloud TheStreet.com
10:36AM  Why Salesforces Revenue Dominance in the Americas Is Good News Market Realist
09:06AM  Could Microsoft Pose a Threat to Salesforce? Market Realist
08:00AM  Today's Research Reports on Stocks to Watch: Salesforce and Autodesk Accesswire
07:47AM  10 Things We Learned From Our Daily Facebook Show With Jim Cramer TheStreet.com
07:36AM  How Growth in CRM Could Benefit Salesforce Market Realist
07:08AM  Here's Why You Should Hold on to Salesforce (CRM) Stock Now Zacks
May-21-17 01:20PM  Salesforce sails into record territory, and analysts see calm waters ahead MarketWatch
12:35PM  Salesforce's Sell-Side Earnings Roundup Benzinga
May-20-17 12:37PM  Salesforce sails into record territory, and analysts see calm waters ahead MarketWatch
08:00AM  Salesforce and Indianapolis Community Celebrate the Grand Opening of Salesforce Tower Indianapolis PR Newswire
May-19-17 07:19PM  Cramers Exec Cut: Why these CEOs are bullish on American... CNBC Videos
04:28PM  Week In Review: Trump Hits Stocks, For A Day; Alibaba, Home Depot, Wal-Mart Strong Investor's Business Daily
04:15PM  Stocks Come Off Highs on More Developments in Trump-Russia Quagmire TheStreet.com
03:09PM  Salesforce's Impressive Growth Continues Forbes
12:30PM  Acosta, Trump's man on Labor, wants more apprenticeships Associated Press
12:28PM  The Pros, The Cons And The Bottom Line In Salesforce's Q1 Earnings Report Benzinga
12:23PM  Cloudy Friendships The Wall Street Journal
12:17PM  Story Stocks from Briefing.com Briefing.com
11:52AM  For Salesforce, The Sum Is Worth More Than The Parts Benzinga
11:24AM  [$$] Salesforce Lifts Its Full-Year Outlook The Wall Street Journal
11:05AM  Salesforce preps guidance feature for its Einstein AI technology ZDNet
10:40AM  How Salesforce Won on Earnings 24/7 Wall St.
10:37AM  Why Salesforce Is Intent on Enhancing Its Offerings Market Realist
10:35AM  Salesforce Rises on Earnings Beat, Growing Cloud Demand: What Wall Street's Saying TheStreet.com
10:21AM  2 Salesforce Q1 Initiatives Warmly Received By Customers Benzinga
09:18AM  Salesforce (CRM) Up on Q1 Earnings Beat and Upbeat Guidance Zacks
09:07AM  A Look at Salesforce Sales Clouds Growth in Fiscal 1Q18 Market Realist
07:45AM  Early movers: DE, FL, CPB, GPS, SYF, CRM & more CNBC
07:37AM  Why Salesforce Einstein Could Be CRMs Highlight in 2017 Market Realist
07:30AM  Salesforce Executive to Participate in Upcoming Investor Event PR Newswire
07:23AM  5 Things You Must Know Before the Market Opens Friday TheStreet.com
06:24AM  Salesforce.com: Cramer's Top Takeaways TheStreet.com
06:00AM  Salesforce: The Future Is Yours Investopedia
02:01AM  PRESS DIGEST - Wall Street Journal - May 19 Reuters
12:09AM  [$$] Salesforce Lifts Its Outlook The Wall Street Journal
May-18-17 07:33PM  How Salesforce CEO Marc Benioff uses artificial intelligence to end internal politics at meetings Business Insider
06:56PM  CRM's Benioff says company 'crushing Oracle' CNBC Videos
06:46PM  Breaking Down Salesforce's First-Quarter Earnings Report Bloomberg Video
06:45PM  Salesforce CEO Marc Benioff says his company is 'crushing... CNBC Videos
06:25PM  Salesforce CEO Marc Benioff says his company is 'crushing Oracle' CNBC
06:17PM  Salesforce's strong results allay slowing growth concerns Reuters
06:06PM  Why Salesforce Launched a New $100 Million Venture Fund Market Realist
05:30PM  Salesforce (CRM) Beats on Earnings and Revenue, Raises Full-Year Guidance Zacks
05:30PM  Salesforce Rising:: Trumpets Rising Profit Margins, Market Share Barrons.com
05:19PM  Salesforce.com Beats Profit, Revenue Views, Tweaks Full-Year Outlook Investor's Business Daily
05:03PM  Salesforce Rising FYQ1, Q2 View Beat, Raises Year Outlook Barrons.com
04:41PM  Salesforce beats on top line CNBC Videos
04:36PM  Chart in Focus: Salesforces Revenue Growth in 2017 Market Realist
04:33PM  Salesforce Sees Increasing Demand on Expanded Cloud Lineup Bloomberg
04:30PM  Salesforce beats on earnings, raises guidance MarketWatch
04:22PM  Salesforce satisfies Q1 targets, ups outlook ZDNet
04:16PM  Salesforce.com reports 1Q loss Associated Press
04:15PM  Salesforce Named #1 CRM Provider For Fourth Consecutive Year PR Newswire
04:11PM  Salesforce quarterly revenue rises 24.6 pct Reuters
04:05PM  Salesforce Announces Fiscal 2018 First Quarter Results PR Newswire
02:43PM  What Pushed Salesforce Stock to Reach an All-Time High? Market Realist
01:26PM  Salesforce On Tap: Looks Like a Modest Beat on Top and Bottom Barrons.com
07:42AM  Atlanta's FullStory raises $15 million from Google, Salesforce; plans 120-job expansion American City Business Journals
07:32AM  Salesforce on track for record earnings despite competition MarketWatch
07:30AM  [$$] Salesforce Earnings: What to Watch The Wall Street Journal
02:00AM  Deloitte Launches Enhanced Digital Banking Offering PR Newswire
May-17-17 04:59PM  Salesforce.com Looking At 'Low Bar' For Q1 Earnings, Billings Investor's Business Daily
03:05PM  Salesforce Looks To Continue Impressive Growth Forbes
09:00AM  Salesforce Commerce Cloud gets AI updates, Android Pay integration ZDNet
08:00AM  Salesforce Extends Commerce Cloud Einstein -- Delivering Personalized AI-Powered Shopping Experiences PR Newswire
May-16-17 02:28PM  Channel Checks Hint At Continued Momentum For Salesforce Benzinga
01:03PM  [$$] Salesforce: 3 Reasons the Stock's Going Higher Barrons.com
09:30AM  Former CEO of Demandware joins venture firm General Catalyst American City Business Journals
09:17AM  The Party's Just Getting Started For Salesforce Benzinga
Salesforce.com, inc. develops enterprise cloud computing solutions with a focus on customer relationship management. The company offers Sales Cloud to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices, as well as solutions for partner relationship management. It also provides Service Cloud, which enables companies to deliver personalized customer service and support, as well as connects their service agents with customers on various devices; and Marketing Cloud to plan, personalize, and optimize one-to-one customer interactions. In addition, the company offers Commerce Cloud to deliver a digital commerce experience; Community Cloud to create and manage branded digital destinations for customers, partners, and employees; Internet of Things Cloud that provides insights to companies enabling them to sell, service, and market to their customers in personalized ways, as well as engage with them in real time; and Analytics Cloud that enables employees across an organization to explore business data, uncover new insights, make decisions, and take action from various devices. Further, it provides Salesforce Quip, a next-generation productivity solution for teams with a mobile-first strategy to collaborate without email; and Salesforce Platform for building enterprise apps. Additionally, the company offers professional cloud services, such as consulting, deployment, training, user-centric design, and integration to facilitate the adoption of its solutions; and architects and innovation program teams, as well as various education services comprising introductory online courses and advanced architecture certifications. Salesforce.com, inc. offers its services through direct sales; and through consulting firms, systems integrators, and other partners. The company was founded in 1999 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Benioff MarcChairman of the Board and CEOMay 26Option Exercise39.0910,000390,92534,195,300May 26 07:58 PM
Norton Burke FEVP and Chief Legal OfficerMay 26Sale90.8580072,67780,733May 26 07:25 PM
Martinez MariaPres., Sales & Cust. SuccessMay 26Sale90.8524722,43934,149May 26 07:28 PM
Harris ParkerCo-FounderMay 26Sale90.8580072,67741,375May 26 07:31 PM
Dayon AlexandrePres. & Chief Product OfficerMay 26Sale90.8580072,67726,223May 26 07:34 PM
Allanson JoeChief Accounting OfficerMay 26Sale90.8520618,71429,087May 26 07:36 PM
Robbins Cynthia G.EVP, Global Employee SuccessMay 26Sale90.8541237,4291,032May 26 07:38 PM
Weaver Amy EPres., Legal & General CounselMay 26Sale90.8540036,33918,154May 26 07:41 PM
Benioff MarcChairman of the Board and CEOMay 26Sale90.8410,000908,37134,185,300May 26 07:58 PM
Norton Burke FEVP and Chief Legal OfficerMay 25Option Exercise0.001,512081,533May 26 07:25 PM
Martinez MariaPres., Sales & Cust. SuccessMay 25Option Exercise0.00648034,396May 26 07:28 PM
Harris ParkerCo-FounderMay 25Option Exercise0.001,512042,175May 26 07:31 PM
Dayon AlexandrePres. & Chief Product OfficerMay 25Option Exercise0.001,512027,023May 26 07:34 PM
Allanson JoeChief Accounting OfficerMay 25Option Exercise0.00540029,293May 26 07:36 PM
Robbins Cynthia G.EVP, Global Employee SuccessMay 25Option Exercise0.001,08001,444May 26 07:38 PM
Weaver Amy EPres., Legal & General CounselMay 25Option Exercise0.00756018,554May 26 07:41 PM
BLOCK KEITHPres., Vice Chairman and COOMay 25Option Exercise37.9510,000379,50010,000May 25 07:04 PM
Benioff MarcChairman of the Board and CEOMay 25Option Exercise39.0910,000390,92534,195,300May 25 07:14 PM
BLOCK KEITHPres., Vice Chairman and COOMay 25Sale90.5310,000905,2580May 25 07:04 PM
Roos John VictorDirectorMay 25Sale90.0419117,19817,956May 25 07:06 PM
Benioff MarcChairman of the Board and CEOMay 25Sale91.1110,000911,09234,185,300May 25 07:14 PM
Benioff MarcChairman of the Board and CEOMay 24Option Exercise39.0910,000390,92534,195,300May 25 07:14 PM
Allanson JoeChief Accounting OfficerMay 24Sale88.4919116,90228,753May 25 04:37 PM
Benioff MarcChairman of the Board and CEOMay 24Sale89.2410,000892,35334,185,300May 25 07:14 PM
BLOCK KEITHPres., Vice Chairman and COOMay 23Option Exercise37.9510,000379,50010,000May 25 07:04 PM
Harris ParkerCo-FounderMay 23Option Exercise39.098,027313,79548,690May 25 07:10 PM
Benioff MarcChairman of the Board and CEOMay 23Option Exercise39.0910,000390,92534,195,300May 25 07:14 PM
Martinez MariaPres., Sales & Cust. SuccessMay 23Sale88.6517715,69033,748May 25 04:25 PM
Hawkins Mark JChief Financial OfficerMay 23Sale88.6549043,43613,076May 25 04:28 PM
Weaver Amy EPres., Legal & General CounselMay 23Sale88.65827,26917,798May 25 04:31 PM
Norton Burke FEVP and Chief Legal OfficerMay 23Sale88.6549043,43680,021May 25 04:34 PM
Allanson JoeChief Accounting OfficerMay 23Sale88.6511810,46028,944May 25 04:37 PM
Dayon AlexandrePres. & Chief Product OfficerMay 23Sale88.6565357,88625,511May 25 04:39 PM
Harris ParkerCo-FounderMay 23Sale88.6549043,43640,663May 25 04:50 PM
BLOCK KEITHPres., Vice Chairman and COOMay 23Sale88.7510,000887,5310May 25 07:04 PM
Harris ParkerCo-FounderMay 23Sale88.598,027711,14340,663May 25 07:10 PM
Benioff MarcChairman of the Board and CEOMay 23Sale88.5810,000885,77234,185,300May 25 07:14 PM
Weaver Amy EPres., Legal & General CounselMay 22Option Exercise0.00154017,880May 22 09:18 PM
Norton Burke FEVP and Chief Legal OfficerMay 22Option Exercise0.00926080,511May 22 09:24 PM
Martinez MariaPres., Sales & Cust. SuccessMay 22Option Exercise0.00463033,925May 22 09:27 PM
Hawkins Mark JChief Financial OfficerMay 22Option Exercise0.00926013,566May 22 09:44 PM
Harris ParkerCo-FounderMay 22Option Exercise0.00926041,153May 22 09:49 PM
Dayon AlexandrePres. & Chief Product OfficerMay 22Option Exercise0.001,235026,164May 22 09:51 PM
Allanson JoeChief Accounting OfficerMay 22Option Exercise0.00309029,062May 22 09:53 PM
Benioff MarcChairman of the Board and CEOMay 22Option Exercise39.0910,000390,92534,195,300May 23 08:41 PM
Benioff MarcChairman of the Board and CEOMay 22Sale88.4610,000884,55234,185,300May 23 08:41 PM
Benioff MarcChairman of the Board and CEOMay 19Option Exercise39.0910,000390,92534,195,300May 19 08:04 PM
Benioff MarcChairman of the Board and CEOMay 19Sale88.2310,000882,33634,185,300May 19 08:04 PM
BLOCK KEITHPres., Vice Chairman and COOMay 18Option Exercise37.9510,000379,50010,000May 18 07:51 PM
Benioff MarcChairman of the Board and CEOMay 18Option Exercise39.0910,000390,92534,195,300May 18 07:26 PM
BLOCK KEITHPres., Vice Chairman and COOMay 18Sale87.6610,000876,6170May 18 07:51 PM
Benioff MarcChairman of the Board and CEOMay 18Sale87.7910,000877,91834,185,300May 18 07:26 PM
Roos John VictorDirectorMay 18Sale87.9019417,05316,647May 18 07:28 PM
Benioff MarcChairman of the Board and CEOMay 17Option Exercise39.0910,000390,92534,195,300May 17 08:09 PM
Benioff MarcChairman of the Board and CEOMay 17Sale88.4210,000884,18834,185,300May 17 08:09 PM
Harris ParkerCo-FounderMay 16Option Exercise39.098,027313,79548,254May 17 07:46 PM
BLOCK KEITHPres., Vice Chairman and COOMay 16Option Exercise37.9510,000379,50010,000May 17 07:49 PM
Benioff MarcChairman of the Board and CEOMay 16Option Exercise39.0910,000390,92534,195,300May 17 08:09 PM
WEBB MAYNARD G JRDirectorMay 16Sale90.012,680241,22731,048May 17 07:40 PM
Harris ParkerCo-FounderMay 16Sale89.798,027720,76040,227May 17 07:46 PM
BLOCK KEITHPres., Vice Chairman and COOMay 16Sale89.8010,000898,0060May 17 07:49 PM
Benioff MarcChairman of the Board and CEOMay 16Sale89.8010,000898,02734,185,300May 17 08:09 PM
Benioff MarcChairman of the Board and CEOMay 15Option Exercise39.0910,000390,92534,195,300May 15 09:24 PM
Benioff MarcChairman of the Board and CEOMay 15Sale89.6310,000896,33534,185,300May 15 09:24 PM
Conway CraigDirectorMay 15Sale89.0625022,2659,102May 15 07:33 PM
Benioff MarcChairman of the Board and CEOMay 12Option Exercise39.0910,000390,92534,195,300May 12 07:51 PM
Benioff MarcChairman of the Board and CEOMay 12Sale88.7210,000887,17134,185,300May 12 07:51 PM
BLOCK KEITHPres., Vice Chairman and COOMay 11Option Exercise37.9510,000379,50010,000May 11 08:36 PM
Benioff MarcChairman of the Board and CEOMay 11Option Exercise39.0910,000390,92534,195,300May 11 08:39 PM
BLOCK KEITHPres., Vice Chairman and COOMay 11Sale86.8010,000868,0160May 11 08:36 PM
Benioff MarcChairman of the Board and CEOMay 11Sale87.2810,000872,79534,185,300May 11 08:39 PM
Roos John VictorDirectorMay 11Sale87.1619416,90916,841May 11 08:42 PM
Benioff MarcChairman of the Board and CEOMay 10Option Exercise39.0910,000390,92534,195,300May 10 07:34 PM
Benioff MarcChairman of the Board and CEOMay 10Sale87.1910,000871,89534,185,300May 10 07:34 PM
Benioff MarcChairman of the Board and CEOMay 09Option Exercise39.0910,000390,92534,195,300May 09 08:58 PM
BLOCK KEITHPres., Vice Chairman and COOMay 09Option Exercise37.9510,000379,50010,000May 09 08:38 PM
Harris ParkerCo-FounderMay 09Option Exercise39.098,027313,79548,254May 09 08:42 PM
Benioff MarcChairman of the Board and CEOMay 09Sale87.2910,000872,94134,185,300May 09 08:58 PM
BLOCK KEITHPres., Vice Chairman and COOMay 09Sale87.1810,000871,7840May 09 08:38 PM
Harris ParkerCo-FounderMay 09Sale87.298,027700,65840,227May 09 08:42 PM
Benioff MarcChairman of the Board and CEOMay 08Option Exercise39.0910,000390,92534,195,300May 08 06:35 PM
Benioff MarcChairman of the Board and CEOMay 08Sale86.8210,000868,24134,185,300May 08 06:35 PM
Benioff MarcChairman of the Board and CEOMay 05Option Exercise39.0910,000390,92534,195,300May 08 06:35 PM
Benioff MarcChairman of the Board and CEOMay 05Sale86.6510,000866,52334,185,300May 08 06:35 PM
Benioff MarcChairman of the Board and CEOMay 04Option Exercise39.0910,000390,92534,195,300May 04 08:17 PM
BLOCK KEITHPres., Vice Chairman and COOMay 04Option Exercise37.9510,000379,50010,000May 04 08:27 PM
Benioff MarcChairman of the Board and CEOMay 04Sale86.6410,000866,41834,185,300May 04 08:17 PM
BLOCK KEITHPres., Vice Chairman and COOMay 04Sale86.6310,000866,3030May 04 08:27 PM
Roos John VictorDirectorMay 04Sale86.7519416,83017,035May 04 08:30 PM
Benioff MarcChairman of the Board and CEOMay 03Option Exercise39.0910,000390,92534,195,300May 03 08:06 PM
Benioff MarcChairman of the Board and CEOMay 03Sale86.4310,000864,29834,185,300May 03 08:06 PM
BLOCK KEITHPres., Vice Chairman and COOMay 02Option Exercise37.9510,000379,50010,000May 02 09:07 PM
Benioff MarcChairman of the Board and CEOMay 02Option Exercise39.0910,000390,92534,195,300May 02 09:11 PM
Harris ParkerCo-FounderMay 02Option Exercise39.098,027313,79548,254May 03 08:02 PM
BLOCK KEITHPres., Vice Chairman and COOMay 02Sale86.5410,000865,3580May 02 09:07 PM
Benioff MarcChairman of the Board and CEOMay 02Sale86.8110,000868,10034,185,300May 02 09:11 PM
Harris ParkerCo-FounderMay 02Sale86.828,027696,91040,227May 03 08:02 PM
Weaver Amy EPres., Legal & General CounselMay 01Option Exercise59.346,438382,03124,164May 02 09:15 PM
Benioff MarcChairman of the Board and CEOMay 01Option Exercise39.0910,000390,92534,195,300May 01 08:09 PM
Wojcicki SusanDirectorMay 01Buy86.641,15499,98727,917May 02 09:21 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-10.57 Insider Own0.20% Shs Outstand337.73M Perf Week1.82%
Market Cap75.35B Forward P/E12.41 EPS next Y17.98 Insider Trans-9.68% Shs Float335.14M Perf Month-8.20%
Income-3688.70M PEG- EPS next Q3.95 Inst Own87.90% Short Float1.93% Perf Quarter-9.39%
Sales14.74B P/S5.11 EPS this Y63.30% Inst Trans-5.36% Short Ratio2.43 Perf Half Y15.55%
Book/sh209.66 P/B1.06 EPS next Y11.57% ROA8.90% Target Price274.59 Perf Year-3.98%
Cash/sh26.50 P/C8.42 EPS next 5Y12.38% ROE15.90% 52W Range184.50 - 261.27 Perf YTD6.24%
Dividend2.80 P/FCF- EPS past 5Y-28.70% ROI0.10% 52W High-14.60% Beta1.16
Dividend %1.25% Quick Ratio1.20 Sales past 5Y26.00% Gross Margin87.60% 52W Low20.93% ATR3.51
Employees16700 Current Ratio1.30 Sales Q/Q5.10% Oper. Margin-17.40% RSI (14)34.23 Volatility1.20% 1.58%
OptionableYes Debt/Eq0.45 EPS Q/Q- Profit Margin80.50% Rel Volume0.64 Prev Close224.36
ShortableYes LT Debt/Eq0.37 EarningsMay 09 BMO Payout2.40% Avg Volume2.66M Price223.12
Recom2.10 SMA20-3.83% SMA50-5.30% SMA200-1.71% Volume1,695,689 Change-0.55%
May-10-17Reiterated RBC Capital Mkts Outperform $279 → $284
May-10-17Downgrade Goldman Buy → Neutral
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
May-26-17 07:00AM  Allergan Announces Closing of Public Offering of Senior Notes to Refinance Existing Debt PR Newswire
May-25-17 02:13PM  Aerie's Ophthalmic Candidate Positive in Registration Trial Zacks
02:01PM  TrumpCare isn't moving health care stocks because it won't pass: NYSE trader Yahoo Finance Video
07:55AM  Getting Struck Twice: Acquisitions & Spinouts In Biotech Forbes
May-24-17 04:30PM  Allergan Announces Pricing of Tender Offers by Certain Subsidiaries PR Newswire
11:19AM  Shark Bites: Focus on the 'Little Picture' TheStreet.com
08:00AM  Allergan Announces Early Tender Results and Upsizing of Tender Offers by Certain Subsidiaries PR Newswire
May-23-17 06:09PM  Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE (Oxymetazoline HCL) Cream, 1% PR Newswire
05:30PM  Allergan Announces Pricing of Public Offering of Senior Notes to Refinance Existing Debt PR Newswire
03:01PM  The biggest CEO pay raises and pay cuts of 2016 Associated Press
02:33PM  The biggest CEO pay raises and pay cuts of 2016 Associated Press
01:26PM  Has Allergan's Pullback Run Its Course? TheStreet.com
10:51AM  Allergan Funding SCS -- Moody's assigns Baa3 to Allergan's euro notes; stable outlook Moody's
06:00AM  These Big Drug Stocks May Cure the Trump Blues Investopedia
03:53AM  Allergan Announces Commencement of Proposed Public Offering of Senior Notes to Refinance Existing Debt PR Newswire
May-22-17 08:27AM  3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter Motley Fool
05:28AM  European stocks edge higher as U.S. political commotion subsides MarketWatch
May-19-17 01:33PM  Valeant Pharmaceuticals: IntriguedReally? Barrons.com
09:48AM  Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA Zacks
May-17-17 10:01AM  Allergan's Irritable Bowel Drug Viberzi Approved in Canada Zacks
09:59AM  Cardiome (CRME) Q1 Loss Wider Than Expected, Sales Miss Zacks
07:20AM  Valeant and Actavis agree to stay litigation relating to Valeant's top-selling drug Xifaxan MarketWatch
May-16-17 01:40PM  Is Editas Facing a New Reality in CRISPR Land? 24/7 Wall St.
12:30PM  Cramer: Carl Icahn Was Right to Sell Apple at $95 TheStreet.com
12:30PM  Carl Icahn Was Right to Sell Apple at $95 TheStreet.com
09:34AM  Biotech Movers: Akebia, Editas, Novavax TheStreet.com
07:45AM  Allergan's Eyepowerment Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications PR Newswire
07:00AM  VIBERZI Now Approved in Canada for patients with irritable bowel syndrome with diarrhea (IBS-D) PR Newswire
May-15-17 08:41PM  Several top fund managers trim Allergan stakes in first quarter Reuters
05:59PM  John Paulson Takes A Shine To Telecom The Wall Street Journal
03:12PM  ETFs with exposure to Allergan Plc : May 15, 2017 Capital Cube
09:28AM  13-F Reveals Tepper's Big Bet on Bank of America Investopedia
08:00AM  Allergan to Present at the Bernstein Strategic Decisions Conference PR Newswire
01:00AM  Still an Allergan Fan; Oil Vey!: Doug Kass' Views TheStreet.com
May-14-17 11:26AM  Edited Transcript of AGN earnings conference call or presentation 9-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-12-17 08:10PM  Earnings Are Still Calling the Tune: Cramer's 'Mad Money' Recap (Friday 5/12/17) TheStreet.com
06:20PM  High-profile Snap stakeholders revealed in filings Reuters
06:03PM  13-F Alert: Starboard Dumps Macy's; Appaloosa and Baupost Lighten up on Allergan Barrons.com
05:19PM  Tepper's Appaloosa Trims Bets on Pharmaceuticals The Wall Street Journal
04:08PM  Court Battle May Be Responsible For Drugmaker's 40% Spike Investor's Business Daily
03:25PM  Top Picks For The Rest Of 2017, Courtesy Of UBS Benzinga
11:38AM  Allergan Plc :AGN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 Capital Cube
08:49AM  Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study Zacks
May-11-17 04:07PM  Hologic Topples On 'Blip' In Breast Health, Body-Sculpting Unit Investor's Business Daily
10:36AM  Understanding Allergans Valuation after the 1Q17 Results Market Realist
09:59AM  Final Trades: Valeant, Allergan and more CNBC Videos
09:08AM  What Happened to Allergans International Segment in 1Q17? Market Realist
08:00AM  Today's Research Reports on Stocks to Watch: Allergan and Celgene Accesswire
07:37AM  Behind Allergans US General Medicines Segment in 1Q17 Market Realist
12:19AM  Asian stocks mostly higher in quiet trading; oil prices gain Associated Press
May-10-17 06:05PM  Behind Allergans US Specialized Therapeutics Segment in 1Q17 Market Realist
04:52PM  4 Pressing Questions We Want Answered When Teva Pharmaceutical Reports Tomorrow Morning Motley Fool
04:45PM  Hologic Smashes Fiscal Q2 Sales Views, Beats On Profit By 4 Cents Investor's Business Daily
04:24PM  Inside Allergans 1Q17 Results: Revenue Streams Market Realist
04:17PM  US STOCKS-Wall St mixed after Trump fires FBI head; Nasdaq hits record high Reuters
03:28PM  Allergan Starts 'Pivotal' 2017 With a Beat, Plus Jim Cramer's Take TheStreet.com
03:02PM  Biotech And Pharma Industry And Stock News Investor's Business Daily
02:17PM  US STOCKS-Wall Street mixed after Trump fires FBI head Reuters
02:05PM  Allergan Looking Shaky After So-So Quarter Investopedia
01:00PM  US STOCKS-Tepid earnings, Comey sacking weigh on Wall St Reuters
11:59AM  Jim Cramer Discusses Disney, Yelp, Nvidia, Allergan, Abercrombie, Macy's and Kohl's TheStreet.com
11:25AM  US STOCKS-Wall St weighed down by weak earnings, Comey sacking Reuters
11:03AM  Jim Cramer on Allergan: There Are So Many Sellers Off the Goldman Downgrade TheStreet.com
11:01AM  Cramer: 5 Timeless Rules When a Stock Breaks Down TheStreet.com
10:04AM  Allergan Stock Falls on Declining U.S. Medicine Revenue, Goldman Downgrade TheStreet.com
08:52AM  Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : May 10, 2017 Capital Cube
08:41AM  Edited Transcript of AGN earnings conference call or presentation 9-May-17 12:30pm GMT Thomson Reuters StreetEvents
06:32AM  Allergan: Cramer's Top Takeaways TheStreet.com
03:00AM  Allergan Announces Tender Offers by Certain Subsidiaries PR Newswire
03:00AM  Allergan Announces Proposed Public Offering of Senior Notes to Refinance Existing Debt PR Newswire
01:08AM  [$$] Thin Is In as Allergan Dodges Generics Bullet The Wall Street Journal
May-09-17 07:11PM  Cramer Remix: Where the money leaving retail stocks could... CNBC Videos
06:59PM  Cramer Remix: Where the money leaving retail stocks could be headed CNBC
05:42PM  Allergan Says It Continues to Look at Stepping-Stone Deals TheStreet.com
04:11PM  Allergan Earnings Top Estimates On Aesthetic, Eye Care Products Investor's Business Daily
01:01PM  Allergan posts loss as it writes down Teva holdings Reuters
12:57PM  Allergan posts loss as it writes down Teva holdings Reuters
11:38AM  [$$] Thin Is In as Allergan Dodges Generics Bullet The Wall Street Journal
10:26AM  Allergan (AGN) Beats Q1 Earnings Estimates, Ups 2017 View Zacks
09:46AM  Ironwood (IRWD) Q1 Loss Wider than Expected, Sales Miss Zacks
09:04AM  Allergan tops Street 1Q forecasts, deal fuels guidance hike Associated Press
08:23AM  Allergan (AGN) Beats Q1 Earnings & Sales; Ups 2017 View Zacks
08:02AM  Early movers: VRX, AGN, W, ODP, PRTY, VZ, WFC, UAL, P & more CNBC
08:00AM  Medicines360 and Allergan Present Four-Year Multi-Center Pivotal Trial Data of LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg at the 2017 ACOG Meeting PR Newswire
07:50AM  UPDATE: Allergan tops earnings estimates on strength of Botox, eye care products MarketWatch
07:00AM  Allergan Reports Solid Start to 2017 with 5% Increase in First Quarter GAAP Net Revenues to $3.6 Billion PR Newswire
06:43AM  Market Recon: Worryingly, the Indices Seem to Be Almost Resting at Lofty Levels TheStreet.com
May-08-17 05:05PM  4 Stocks In Buy Range Ahead Of Earnings Reports: Investing Action Plan Investor's Business Daily
04:28PM  Allergan's Q1 Sales Expected To Slip As Jazz Pharma Outperforms Investor's Business Daily
04:00PM  M&A Talks May Take Center Stage in Allergan's 1Q Earnings Call TheStreet.com
03:21PM  Allergan Must Show Mergers, Drug Pipeline Can Make Up For Lost Sales TheStreet.com
01:05PM  Allergan: Analysts Ratings and Recommendations Market Realist
11:26AM  Analyzing Allergans 1Q17 Revenue Estimates Market Realist
11:26AM  Allergans 1Q17 Earnings: Analysts Estimates Market Realist
May-07-17 11:06AM  Earnings Preview: What To Expect From Allergan On Tuesday Forbes
May-05-17 08:00AM  Allergan Announces Second Quarter 2017 Cash Dividend of $0.70 Per Ordinary Share PR Newswire
May-04-17 05:05PM  Here's Why Paratek Pharmaceuticals Rose as Much as 16.1% Today Motley Fool
10:34AM  What's in the Cards for Allergan (AGN) this Earnings Season? Zacks
08:00AM  Allergan to Present at the Bank of America Merrill Lynch Healthcare Conference PR Newswire
07:30AM  Allergan to Present New Data at the 2017 American College of Obstetricians and Gynecologists (ACOG) Clinical and Scientific Meeting in San Diego PR Newswire
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, the company distributes generic and branded pharmaceutical products primarily to independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics, and physician offices. Further, it develops a portfolio of breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. The company has licensing agreement with Assembly Biosciences, Inc.; Mimetogen Pharmaceuticals, Inc.; Almirall, S.A; Naurex, Inc.; and Merck & Co. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Basgoz NesliDirectorMay 18Option Exercise84.441,889159,5077,919May 22 04:26 PM
Basgoz NesliDirectorMay 18Sale220.451,889416,4306,030May 22 04:26 PM
GALLAGHER MICHAEL RDirectorMay 04Option Exercise245.2517,6934,339,20820,272May 05 06:34 PM
BISARO PAULDirectorMar 02Sale246.6870,00017,267,561235,900Mar 06 06:59 AM
Meury WilliamChief Commercial OfficerDec 08Option Exercise109.1211,8071,288,38048,866Feb 14 09:13 PM
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM
ADBE Adobe Systems Incorporated daily Stock Chart
ADBE [NASD]
Adobe Systems Incorporated
IndexS&P 500 P/E54.30 EPS (ttm)2.61 Insider Own0.10% Shs Outstand498.04M Perf Week4.00%
Market Cap70.67B Forward P/E28.45 EPS next Y4.99 Insider Trans-51.51% Shs Float493.06M Perf Month6.38%
Income1.31B PEG2.78 EPS next Q0.95 Inst Own89.50% Short Float0.95% Perf Quarter19.46%
Sales6.15B P/S11.49 EPS this Y86.70% Inst Trans0.78% Short Ratio2.02 Perf Half Y36.16%
Book/sh15.34 P/B9.25 EPS next Y26.25% ROA10.40% Target Price145.07 Perf Year42.79%
Cash/sh9.34 P/C15.20 EPS next 5Y19.50% ROE17.80% 52W Range90.35 - 143.48 Perf YTD37.82%
Dividend- P/FCF31.49 EPS past 5Y7.00% ROI13.20% 52W High-1.11% Beta0.99
Dividend %- Quick Ratio1.90 Sales past 5Y6.80% Gross Margin86.00% 52W Low57.04% ATR1.67
Employees15706 Current Ratio1.90 Sales Q/Q21.60% Oper. Margin26.90% RSI (14)72.34 Volatility1.21% 1.11%
OptionableYes Debt/Eq0.25 EPS Q/Q58.20% Profit Margin21.30% Rel Volume0.69 Prev Close142.85
ShortableYes LT Debt/Eq0.25 EarningsJun 20 AMC Payout0.00% Avg Volume2.32M Price141.89
Recom1.80 SMA203.89% SMA507.28% SMA20024.32% Volume1,601,581 Change-0.67%
May-25-17Reiterated RBC Capital Mkts Outperform $135 → $157
Apr-13-17Initiated Guggenheim Buy
Apr-12-17Initiated Stifel Buy $150
Mar-24-17Upgrade Credit Suisse Neutral → Outperform
Mar-17-17Upgrade Wunderlich Hold → Buy
Mar-17-17Reiterated RBC Capital Mkts Outperform $130 → $135
Mar-17-17Reiterated Pivotal Research Group Hold $104 → $109
Mar-17-17Reiterated BMO Capital Markets Outperform $125 → $140
Feb-28-17Resumed Robert W. Baird Outperform $125 → $130
Feb-08-17Reiterated RBC Capital Mkts Outperform $115 → $125
Jan-12-17Downgrade Pivotal Research Group Buy → Hold $136 → $104
Jan-11-17Initiated Wells Fargo Market Perform
Jan-05-17Initiated BMO Capital Markets Outperform $125
Nov-03-16Reiterated Wunderlich Hold $99 → $115
Sep-21-16Reiterated RBC Capital Mkts Outperform $115 → $116
Sep-21-16Reiterated Pivotal Research Group Buy $124 → $125
Jul-26-16Initiated Piper Jaffray Overweight $125
Jun-22-16Reiterated UBS Buy $114 → $122
Jun-22-16Reiterated Rosenblatt Buy $112 → $120
Apr-21-16Resumed Credit Suisse Neutral $85 → $105
May-26-17 05:26PM  [$$] Funding Snapshot: Demandbase Raises $65 Million Late Stage Round The Wall Street Journal
May-24-17 04:05PM  3 Growth Stocks for Those Moving Up in the World Motley Fool
10:37AM  Bernstein's Favorites In The US SMID-Cap Software Space Benzinga
08:14AM  3 Reasons Apple Should Not Pay $90 Billion For Adobe Systems Forbes
May-23-17 11:20AM  Adobe Systems Is Extended on the Upside TheStreet.com
06:46AM  Adobe Systems (ADBE) Scales a New 52-Week High of $139.2 Zacks
May-22-17 07:01PM  Cramer: Get Your Head Into the Cloud TheStreet.com
08:12AM  3 Top Stocks for Your IRA Motley Fool
May-19-17 04:07PM  Oh Canada! Is Shopify A Buyer After Surprise Stock Offering? Investor's Business Daily
May-12-17 06:41PM  From baseball to liquor, Tableau Software CEO explains ho... CNBC Videos
04:51PM  SAP Sapphire Now Yahoo Finance Video
04:42PM  SAP Sapphire Now Yahoo Finance Video
12:45PM  Want To Sharpen Your Stock Buys, Catch Breakouts? Consult This New IBD Feature Investor's Business Daily
May-11-17 06:49PM  Cramer's lightning round: If you're playing the cloud, this stock is the one to own CNBC
01:21PM  TechCrunch Disrupt NY 2017 Yahoo Finance Video
May-10-17 04:44PM  3 Cloud Computing Stocks To Buy Right Now Zacks
09:31AM  3 Growth Stocks for Astute Investors Motley Fool
May-09-17 05:44PM  Pioneer Investments Buys Broadcom, Adobe, FedEx GuruFocus.com
May-05-17 07:16PM  Cramer: With Buffett scaling out, here's the transformati... CNBC Videos
May-04-17 10:17AM  The best Silicon Valley companies for new dads, led by Netflix American City Business Journals
May-03-17 06:30AM  Cramer Off the Charts: It's Not Just the FAANG Stocks TheStreet.com
May-02-17 06:21PM  Cramer's charts reveal the real drivers of the Nasdaq's rally CNBC
04:03PM  Facebook Price Target Hiked On Instagram, Adobe A Buy On Cloud, AMD Cut Investor's Business Daily
12:59PM  Why Netflix Is Winning the Online Piracy Wars Bloomberg
09:02AM  Analysts' Actions -- Adobe, AMD, Chegg, Okta and More TheStreet.com
Apr-27-17 08:10AM  Citrix Systems (CTXS) Beats on Earnings & Revenues in Q1 Zacks
07:36AM  What Analysts Recommend for Honeywell Market Realist
Apr-26-17 10:51AM  Amphenol (APH) Beats on Q1 Earnings, Raises 2017 Guidance Zacks
Apr-25-17 10:38AM  How Salesforces Subscription Segment Has Been Performing Market Realist
10:00AM  It's Not Enough to Give Employees Flexible Work Schedules Bloomberg
07:39AM  How the Microsoft-Adobe Partnership Threatens Salesforce Market Realist
Apr-22-17 10:15AM  Oracle's Latest Acquisition Shows the Ad Software Arms Race Remains in Full Swing TheStreet.com
Apr-21-17 10:39AM  Top Ranked Growth Stocks to Buy for April 21st Zacks
Apr-20-17 08:22AM  Colgate, Adobe, and 2 More Are Ready to Rip Higher This Spring TheStreet.com
Apr-19-17 02:28PM  Adobe Creative Cloud Propels Video Forward at NAB 2017 Business Wire
09:00AM  Adobe Named a Leader in Gartner Magic Quadrant for Multichannel Campaign Management Business Wire
Apr-17-17 12:45PM  ETFs with exposure to Adobe Systems, Inc. : April 17, 2017 Capital Cube
07:56AM  Adobe (ADBE) Up 5.5% Since Earnings Report: Can It Continue? Zacks
Apr-13-17 01:34PM  Guggenheim: Adobe could rally 20% CNBC Videos
09:17AM  3 Best Stocks for Your Roth IRA Motley Fool
08:21AM  Early movers: JPM, PNC, AAPL, DIS, GS, WFC, TSLA, SEAS & more CNBC
Apr-12-17 12:34PM  10 Companies That Offer The Best Paid Paternity Leave Benefits Insider Monkey
11:05AM  Analysts' Actions -- Lululemon, L Brands, Masco, Under Armour and More TheStreet.com
Apr-11-17 11:00AM  A new app could solve the biggest problems with selfies Business Insider
Apr-10-17 12:39PM  Virtual Reality Storytellers Are Ready To Get Into Your Headset Forbes
12:06PM  Splunk's Move to Subscriptions Could Signal Huge Gains for the Stock Motley Fool
Apr-08-17 09:35AM  Big Tech and Biotech Trades Highlight Insider Selling: Gap, Adobe, Celgene, Splunk and More 24/7 Wall St.
Apr-07-17 09:00AM  Adobe Named the Leader Among Digital Intelligence Platform Vendors by Independent Research Firm Business Wire
Apr-05-17 04:27PM  7 Stocks Beating the Market GuruFocus.com
04:14PM  ETFs with exposure to Adobe Systems, Inc. : April 5, 2017 Capital Cube
09:41AM  Adobe Is Going All In on AI Motley Fool
Apr-04-17 04:23PM  3 Cloud Computing Stocks To Buy Right Now Zacks
09:25AM  Adobe Systems, Inc. :ADBE-US: Earnings Analysis: Q1, 2017 By the Numbers : April 4, 2017 Capital Cube
Mar-31-17 11:36AM  Stocks set to post best Q1 in 4 years Yahoo Finance
Mar-30-17 01:56PM  Adobe Tests AI-Driven Photo Retouching Tool at Investopedia
Mar-29-17 04:14PM  ADOBE SYSTEMS INC Files SEC form 10-Q, Quarterly Report
02:31PM  Stocks Mixed, Nasdaq Up; Can These 6 Names Become 'The Next Cisco' Of 2010s? Investor's Business Daily
08:15AM  Post Earnings Coverage as Adobe Reported Record Breaking Quarter; Revenue Gew 22% and Adjusted EPS Soared 42% Accesswire
Mar-28-17 07:47PM  Many of Silicon Valley's biggest companies are absent from San Jose flood-relief efforts at bizjournals.com
07:47PM  Many of Silicon Valley's biggest companies are absent from San Jose flood-relief efforts American City Business Journals
08:54AM  Is Adobe Systems Getting Ready for Another Jump Higher? TheStreet.com
08:32AM  Looking for a Top Momentum Stock? 3 Reasons Why Adobe Systems (ADBE) is a Great Choice Zacks
Mar-27-17 04:09PM  Trader tracker: Q1's most memorable calls at CNBC
01:51PM  Adobe Price Estimate Revised To $132, Here's Why at Forbes
11:05AM  Jim Cramer: We Like Adobe for Action Alerts PLUS at TheStreet
10:20AM  Merrill Lynch Out With Revised 6 Top Software Stock Picks to Buy Now 24/7 Wall St.
09:31AM  Zacks.com featured highlights: CBRE Group, Wabash National, Honda Motor, Universal Forest Products and Adobe Systems
08:52AM  Adobe (ADBE) Stock Gains as Credit Suisse Ups Price Target
08:49AM  Looking for a Growth Stock? Why It is Time to Focus on Adobe Systems (ADBE)
08:26AM  Analysts' Actions -- Adobe, Starbucks, Snap, KB Home and More
12:06AM  [$$] Why PTCs Revenue Still Raises Eyebrows at The Wall Street Journal
Mar-26-17 04:40PM  How Adobe Can Plug the Hole in Its Cloud at TheStreet
09:27AM  3 of the Safest Stocks You Can Buy Right Now at Motley Fool
09:22AM  [$$] Why PTC's Revenue Still Raises Eyebrows at The Wall Street Journal
Mar-25-17 10:40AM  Massive Biotech Trade Highlights Insider Selling: Esperion Therapeutics, Adobe, Hilton, Fresh Del Monte and More
Mar-24-17 04:13PM  Apple, Adobe Price Targets Hiked; Under Armour, Micron Upgraded
03:42PM  Stocks Mixed on Reports Health Care Bill Has Been Pulled
12:15PM  Adobe Systems Stock Rising on Credit Suisse Upgrade at TheStreet
11:06AM  Microsoft and Adobe Flat as Companies Integrate Sales and Marketing Data Gurufocus
10:59AM  Stocks Higher as Trump Faces a Test on the Health Care Vote
10:48AM  7 Stocks to Buy with Impressive Interest Coverage Ratio
10:23AM  Tech Today: Micron Surges, GameStop Drops, Even More Apple Plaudits at Barrons.com
08:32AM  Analysts' Actions -- Adobe, Macy's, Roper, Under Armour and More
12:22AM  [$$] High-Court Case to Challenge Jurisdiction Shopping in Patent Suits at The Wall Street Journal
Mar-23-17 05:40PM  How Adobe Can Plug the Holes in Its Cloud at TheStreet
08:08AM  Watch now: BizWireTV Brings You the Richest People in the World Find Out Who Made the Cut, and Shopping Tech as Easy as Asking for What You Want Business Wire
06:22AM  [video]Starbucks: Cramer's Top Takeaways
05:30AM  [$$] How a Patent Case May Shake Up Domination of Eastern Texas at The Wall Street Journal
Mar-22-17 11:19PM  Adobe is Piecing Together Different Parts of Its Marketing Software Empire
07:36PM  Adobe CEO on Microsoft Partnership, A.I. and M&A
07:36PM  Adobe CEO on Microsoft Partnership, A.I. and M&A at Bloomberg
07:28PM  Adobe CEO Focused on Microsoft Partnership and A.I.
07:28PM  Adobe CEO Focused on Microsoft Partnership and A.I. at Bloomberg
06:39PM  Markets Subdued as Trump Trade Slumps: Cramer's 'Mad Money' Recap (Wednesday 3/22/17)
04:40PM  Indexes inch back upward as tech stocks rise; Nike plunges
03:18PM  Is Adobe Still a Buy After 22% Gains? at Investopedia
02:38PM  Adobe Unveils New Enterprise Cloud Solution at Investopedia
11:59AM  Top Research Reports for Netflix, Goldman Sachs & Kinder Morgan
09:00AM  AI, VR, IoT and Kate McKinnon Headline Adobe Summit Sneaks Business Wire
07:35AM  Salesforce Gives Microsoft Another Reason to Worry at Market Realist
Adobe Systems Incorporated operates as a diversified software company worldwide. Its Digital Media segment provides tools and solutions that enable individuals, small and medium businesses, and enterprises to create, publish, promote, and monetize their digital content. This segment's flagship product is Creative Cloud, a subscription service that allows customers to download and install the latest versions of its creative products. This segment serves traditional content creators, Web application developers, and digital media professionals, as well as their management in marketing departments and agencies, companies, and publishers. The company's Digital Marketing segment offers solutions for how digital advertising and marketing are created, managed, executed, measured, and optimized. This segment provides analytics, social marketing, targeting, advertising and media optimization, digital experience management, cross-channel campaign management, and audience management solutions, as well as video delivery and monetization to digital marketers, advertisers, publishers, merchandisers, Web analysts, chief marketing officers, chief information officers, and chief revenue officers. Its Print and Publishing segment offers products and services, such as eLearning solutions, technical document publishing, Web application development, and high-end printing, as well as publishing needs of technical and business, and original equipment manufacturers (OEMs) printing businesses. The company markets and licenses its products and services directly to enterprise customers through its sales force, as well as to end-users through app stores and through its Website at adobe.com. It also distributes products and services through a network of distributors, value-added resellers, systems integrators, independent software vendors, retailers, and OEMs. The company was founded in 1982 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lewnes AnnEVP, Chief Marketing OfficerMay 10Sale135.862,233303,37564,177May 11 06:27 PM
Lewnes AnnEVP, Chief Marketing OfficerApr 12Sale129.962,233290,20166,410Apr 13 04:17 PM
DALEY JAMES EDirectorApr 11Option Exercise0.002,801030,887Apr 13 04:14 PM
Banse AmyDirectorApr 11Option Exercise0.002,801030,592Apr 13 04:12 PM
Desmond LauraDirectorApr 11Option Exercise0.002,801023,852Apr 13 04:14 PM
GESCHKE CHARLES MDirectorApr 11Option Exercise0.002,8010172,024Apr 13 04:15 PM
ROSENSWEIG DANIELDirectorApr 11Option Exercise0.002,801015,801Apr 13 04:15 PM
BARNHOLT EDWARD WDirectorApr 11Option Exercise0.002,801035,925Apr 13 04:13 PM
BURGESS ROBERT KDirectorApr 11Option Exercise0.002,801039,925Apr 13 04:13 PM
CALDERONI FRANKDirectorApr 11Option Exercise0.002,801023,852Apr 13 04:14 PM
LAMKIN BRYANEVP & GM, Digital MediaMar 31Sale130.3020,0002,605,95052,083Mar 31 07:29 PM
Lewnes AnnEVP, Chief Marketing OfficerMar 22Sale125.002,233279,12568,643Mar 24 04:05 PM
GESCHKE CHARLES MDirectorMar 20Sale125.9559,5507,500,060169,223Mar 21 04:25 PM
LAMKIN BRYANEVP & GM, Digital MediaMar 15Option Exercise0.0019,750082,388Mar 17 04:27 PM
GARRETT MARKEVP, CFO & Asst. SecretaryFeb 06Sale114.1245,1995,158,0864,339Feb 07 04:10 PM
BURGESS ROBERT KDirectorFeb 02Option Exercise42.6125,0001,065,25062,124Feb 03 04:11 PM
BURGESS ROBERT KDirectorFeb 02Sale113.1925,0002,829,71037,124Feb 03 04:11 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 27Sale113.0810,4401,180,54447,482Jan 27 04:14 PM
Rencher BradleyEVP & GM, Digital MarketingJan 25Sale113.9640,0004,558,27650,735Jan 26 04:14 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 25Sale113.7855,0006,257,92851,919Jan 26 04:14 PM
NARAYEN SHANTANUPresident and CEOJan 25Sale113.91173,70319,787,246299,243Jan 26 04:13 PM
Rencher BradleyEVP & GM, Digital MarketingJan 24Option Exercise0.0080,7200101,620Jan 26 04:14 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 24Option Exercise0.0013,748010,098Jan 26 04:14 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 24Option Exercise0.00113,7560131,387Jan 26 04:14 PM
LAMKIN BRYANEVP & GM, Digital MediaJan 24Option Exercise0.0080,153078,016Jan 26 04:12 PM
Lewnes AnnEVP, Chief Marketing OfficerJan 24Option Exercise0.0056,620080,588Jan 26 04:12 PM
Morris DonnaEVP, Cust. & Emp. ExperienceJan 24Option Exercise0.0056,620089,524Jan 26 04:13 PM
NARAYEN SHANTANUPresident and CEOJan 24Option Exercise0.00363,2400549,812Jan 26 04:13 PM
Parasnis AbhayEVP & CTOJan 24Option Exercise0.008,16508,436Jan 26 04:13 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 24Option Exercise0.0056,036068,744Jan 26 04:12 PM
GARRETT MARKEVP, CFO & Asst. SecretaryJan 24Option Exercise0.00103,587071,082Jan 26 04:12 PM
DALEY JAMES EDirectorJan 20Option Exercise33.2310,000332,30038,086Jan 23 04:58 PM
DALEY JAMES EDirectorJan 20Sale110.0210,0001,100,20028,086Jan 23 04:58 PM
WARNOCK JOHN ECo-Chairman of the BoardJan 17Sale107.285,000536,405559,600Jan 17 04:14 PM
GESCHKE CHARLES MCo-Chairman of the BoardJan 09Sale108.5223,1002,506,775228,773Jan 09 06:24 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 06Sale108.131,348145,7600Jan 06 06:54 PM
GESCHKE CHARLES MCo-Chairman of the BoardJan 04Sale104.0348,1005,003,800251,873Jan 05 04:20 PM
WARNOCK JOHN ECo-Chairman of the BoardDec 19Sale105.416,000632,472565,600Dec 21 04:43 PM
Morris DonnaEVP, Cust. & Emp. ExperienceOct 10Sale110.0010,0001,100,00054,279Oct 11 04:43 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryOct 10Sale109.6413,3311,461,57930,993Oct 11 04:41 PM
WARNOCK JOHN ECo-Chairman of the BoardSep 27Sale106.995,000534,950571,600Sep 27 04:49 PM
ROSENSWEIG DANIELDirectorSep 26Sale107.4213,0001,396,4266,268Sep 27 04:47 PM
DALEY JAMES EDirectorSep 22Option Exercise33.236,276208,55134,362Sep 23 05:00 PM
DALEY JAMES EDirectorSep 22Sale108.006,276677,80828,086Sep 23 05:00 PM
GARRETT MARKEVP, CFO & Asst. SecretarySep 06Sale103.4726,8992,783,3120Sep 06 07:01 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryAug 29Sale101.855,450555,08344,324Aug 29 06:11 PM
Lewnes AnnEVP, Chief Marketing OfficerAug 26Sale101.6813113,32042,968Aug 29 04:29 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryAug 23Option Exercise0.0027,500064,123Aug 24 04:08 PM
GARRETT MARKEVP, CFO & Asst. SecretaryAug 16Option Exercise0.0056,250056,250Aug 17 04:31 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Option Exercise34.032,33579,46076,614Aug 11 04:05 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Sale100.0010,0001,000,00064,279Aug 11 05:06 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Sale100.002,335233,50074,279Aug 11 04:05 PM
Lewnes AnnEVP, Chief Marketing OfficerJul 29Sale98.404,000393,60043,099Aug 01 04:09 PM
DALEY JAMES EDirectorJul 20Option Exercise33.235,000166,15033,086Jul 21 04:08 PM
WARNOCK JOHN ECo-Chairman of the BoardJul 20Sale98.512,000197,024579,115Jul 21 04:10 PM
DALEY JAMES EDirectorJul 20Sale98.505,000492,50028,086Jul 21 04:08 PM
BARNHOLT EDWARD WDirectorJul 11Option Exercise37.0925,000927,25058,124Jul 11 05:56 PM
BARNHOLT EDWARD WDirectorJul 11Sale97.2525,0002,431,13333,124Jul 11 05:56 PM
Rencher BradleyEVP & GM, Digital MarketingJul 01Sale95.4637,5623,585,62747,269Jul 01 05:38 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJul 01Sale95.6827125,9291,348Jul 01 04:13 PM
LAMKIN BRYANEVP & GM, Digital MediaJul 01Sale95.049,616913,90523,665Jul 01 04:10 PM
WARNOCK JOHN ECo-Chairman of the BoardJun 30Sale95.154,000380,605581,115Jul 01 04:09 PM
ROSENSWEIG DANIELDirectorJun 29Sale92.9819,3001,794,57419,268Jul 11 04:57 PM
Lewnes AnnEVP, Chief Marketing OfficerJun 24Sale92.394,000369,56046,828Jun 24 04:32 PM
SHPG Shire plc daily Stock Chart
SHPG [NASD]
Shire plc
Index- P/E95.36 EPS (ttm)1.86 Insider Own0.10% Shs Outstand314.69M Perf Week-6.32%
Market Cap55.76B Forward P/E10.35 EPS next Y17.12 Insider Trans0.00% Shs Float302.22M Perf Month-0.37%
Income548.80M PEG6.86 EPS next Q3.53 Inst Own22.10% Short Float0.26% Perf Quarter-3.12%
Sales13.26B P/S4.21 EPS this Y-65.50% Inst Trans-4.51% Short Ratio0.78 Perf Half Y1.90%
Book/sh98.66 P/B1.80 EPS next Y14.08% ROA0.40% Target Price242.49 Perf Year-6.87%
Cash/sh- P/C- EPS next 5Y13.90% ROE1.00% 52W Range161.09 - 209.22 Perf YTD3.99%
Dividend0.91 P/FCF- EPS past 5Y-12.80% ROI2.10% 52W High-15.31% Beta1.57
Dividend %0.51% Quick Ratio0.50 Sales past 5Y22.30% Gross Margin63.10% 52W Low9.99% ATR3.60
Employees23906 Current Ratio1.00 Sales Q/Q109.00% Oper. Margin6.90% RSI (14)42.36 Volatility1.72% 1.54%
OptionableYes Debt/Eq0.76 EPS Q/Q-43.60% Profit Margin2.10% Rel Volume1.68 Prev Close184.82
ShortableYes LT Debt/Eq0.66 EarningsMay 02 BMO Payout100.40% Avg Volume987.07K Price177.18
Recom1.60 SMA20-3.09% SMA50-0.25% SMA200-1.63% Volume1,661,063 Change-4.13%
May-26-17Downgrade Bernstein Outperform → Mkt Perform
May-19-17Downgrade HSBC Securities Hold → Reduce
Mar-09-17Initiated Liberum Buy
Dec-02-16Initiated Societe Generale Buy
Sep-26-16Downgrade HSBC Securities Buy → Hold
Jun-03-16Reiterated Jefferies Buy $223 → $262
May-26-16Initiated Stifel Buy $230
May-06-16Initiated Liberum Buy
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-10-16Upgrade RBC Capital Mkts Sector Perform → Outperform $240 → $240
Feb-10-16Initiated Guggenheim Neutral
Jan-15-16Upgrade BofA/Merrill Neutral → Buy
Jan-12-16Upgrade Credit Suisse Neutral → Outperform
Jan-12-16Reiterated RBC Capital Mkts Sector Perform $248 → $240
Nov-17-15Upgrade Leerink Partners Mkt Perform → Outperform $239
Nov-03-15Upgrade HSBC Securities Hold → Buy
Oct-26-15Reiterated RBC Capital Mkts Sector Perform $263 → $248
Oct-14-15Initiated Northland Capital Outperform $288
Sep-30-15Upgrade HSBC Securities Reduce → Hold
Aug-06-15Downgrade Exane BNP Paribas Outperform → Neutral
May-25-17 03:06PM  Why BioCryst Pharmaceuticals Stock Caught Fire Today Motley Fool
07:00AM  Shire to Participate at the Jefferies Healthcare Conference PR Newswire
May-24-17 09:17AM  Ultragenyx Receives Priority Review for rhGUS from FDA Zacks
May-22-17 01:05PM  Shire and tiny Lexington biotech say hemophilia drug trial misses mark American City Business Journals
May-19-17 05:21PM  Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug Zacks
12:48PM  Biotech And Pharma Industry And Stock News Investor's Business Daily
10:17AM  Company News for May 19, 2017 Zacks
08:15AM  Blog Coverage: Shire's Stock Price Jumped on Positive Results in Hereditary Angioedema Treatment Accesswire
07:43AM  Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More Zacks
01:00AM  Shire to Highlight New Research Into Chronic Hypoparathyroidism at the European Congress of Endocrinology PR Newswire
May-18-17 05:27PM  Drugmaker Leads Industry Gains Thursday On Rare Disease Trial Investor's Business Daily
05:11PM  [$$] Biotech Investor Clarus Ventures Raising $880 Million Fund The Wall Street Journal
11:54AM  Shire's swelling disorder drug moves closer to U.S. approval Reuters
11:15AM  Shire gains $2B in market cap as rare disease drug aces late-stage trial American City Business Journals
09:00AM  The Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates in Patients with Moderate-to-Severe Ulcerative Colitis PR Newswire
07:18AM  Shire ADRs jump almost 7% premarket after positive trial of Angioedema treatment MarketWatch
07:00AM  Shire's Investigational Treatment Lanadelumab Reduces Hereditary Angioedema Monthly Attack Rate by 87% Versus Placebo in Phase 3 26-week Pivotal Trial PR Newswire
May-16-17 04:55PM  [$$] Health-Care Investor Agent Capital Seeks $100 Million Fund The Wall Street Journal
07:00AM  Shire Continues 20-Year Commitment to ADHD with New Research at 2017 Annual Meeting of American Psychiatric Association PR Newswire
May-15-17 04:37PM  ETFs with exposure to Shire Plc : May 15, 2017 Capital Cube
May-05-17 04:33PM  ETFs with exposure to Shire Plc : May 5, 2017 Capital Cube
10:37AM  Keryx (KERX) Q1 Loss Wider than Expected, Revenues Beat Zacks
May-04-17 11:10AM  Shire Plc :SHPG-US: Earnings Analysis: Q1, 2017 By the Numbers : May 4, 2017 Capital Cube
May-03-17 11:17AM  Shire (SHPG) Beats on Q1 Earnings & Sales, Reiterates View Zacks
10:32AM  Momenta (MNTA) Q1 Loss Narrower than Expected, Sales Beat Zacks
May-02-17 09:23AM  [$$] Shire Profit Pressured by Baxalta Takeover Costs The Wall Street Journal
09:10AM  Durham CEO on deal with Shire valued at up to $535M American City Business Journals
08:42AM  Shire Stock Lifted By First-Quarter Earnings Beat TheStreet.com
07:27AM  Shire tops Street 1Q forecasts Associated Press
07:00AM  Shire Delivers Strong Q1 2017 Revenue Growth While Advancing Late-stage Pipeline PR Newswire
May-01-17 07:00AM  Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications PR Newswire
Apr-26-17 01:00AM  Shire Granted EU Conditional Marketing Authorisation for Natpar (Parathyroid Hormone) for the Treatment of Patients with Chronic Hypoparathyroidism PR Newswire
Apr-25-17 03:48PM  ETFs with exposure to Shire Plc : April 25, 2017 Capital Cube
08:15AM  Blog Coverage Eli Lilly's Breast Cancer Drug Achieved its Primary Endpoint in Late Stage Trial Accesswire
07:00AM  Shire to Participate at the Deutsche Bank 42nd Annual Health Care Conference PR Newswire
Apr-24-17 01:00AM  Shire Launches #PIPostsThanks Social Campaign to Raise Awareness of Primary Immunodeficiency (PI) PR Newswire
Apr-17-17 01:00AM  Shire plc: Data Show A Bleeding Episode Occurs Every Three to 15 Seconds in People Living With Hemophilia Worldwide PR Newswire
Apr-10-17 07:00AM  PatientsLikeMe and Shire Pharmaceuticals Collaborate to Study Rare Genetic Diseases Business Wire
Apr-06-17 08:22AM  Novartis Licenses ECF843 Eye Drops From Lubris Investopedia
Apr-04-17 11:12AM  Shire Plc : SHPG-US: Dividend Analysis : March 10th, 2017 (record date) : By the numbers : April 4, 2017 Capital Cube
Apr-03-17 01:48PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mar-30-17 04:41AM  INTUNIV® (Guanfacine Hydrochloride Prolonged Release), a Non-stimulant for the Treatment of ADHD, Receives Approval in Japan PR Newswire
Mar-28-17 04:50PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Mar-27-17 01:32PM  Shire: Can It Pay Down Debt? Barrons.com
Mar-23-17 05:03PM  Shire (SHPG) Rare Disease Drug Gets Fast Track Designation Zacks
Mar-22-17 10:27AM  Shire hTTP Drug Secures Fast Track Designation Investopedia
07:00AM  Shire Receives FDA Fast Track Designation for Recombinant ADAMTS13 (SHP655) for Treatment of Hereditary Thrombotic Thrombocytopenic Purpura PR Newswire
Mar-21-17 09:55AM  Is Shire Stock a Good Choice for Value Investors Now? Zacks
Mar-16-17 07:14PM  Shire's (SHPG) Cinryze Label Expanded for Pediatric Use Zacks
10:40AM  Shires Cinryze Drug Gets EU Label Expansion Investopedia
02:00AM  Shire Receives European Approval for Label Extension of CINRYZE®(C1 inhibitor ) to Prevent and Treat Hereditary Angioedema (HAE) Attacks in Paediatric Patients with HAE PR Newswire
Mar-13-17 02:50PM  Whats that thing on top of the Sanofi-Genzyme building anyway? at bizjournals.com
02:31PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Mar-10-17 04:25PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
01:20PM  Biogen Spinoff Takes Flight With Focus On Hemophilia Drugs
Mar-09-17 08:49AM  Coverage initiated on Shire plc by Liberum
Mar-07-17 12:48PM  European Stocks Mixed as Frankfurt Rises, Paris Falls
Mar-06-17 01:55PM  CUVITRU Data Demonstrate Improved Treatment Satisfaction Relative to Patients' Previous Immunoglobulin Therapy PR Newswire
Mar-03-17 12:34PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Mar-02-17 05:08PM  Merrimack (MACK) Q4 Loss Lower than Expected, Revenues Top
12:34PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
12:12PM  These 3 Big Pharma Stocks Are Exceptionally Cheap at Motley Fool
Mar-01-17 05:02PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Shire to Participate at the Cowen 37th Annual Healthcare Conference PR Newswire
Feb-28-17 01:04PM  SHIRE PLC Financials
09:55AM  Amicus Therapeutics Launches Galafold in UK at Investopedia
Feb-27-17 06:00AM  Drugmakers Eye $35B Market Amid Obesity Crisis at Investopedia
01:01AM  argenx announces extension of therapeutic antibody alliance with Shire GlobeNewswire
Feb-24-17 04:42PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:21PM  NASH Is Todd Hagopian's Top Biotech Sub-Sector For 2017 at Forbes
10:02AM  Patient Dies In Roche Hemophilia Study at Investopedia
08:15AM  Blog Coverage Novartis Gains Priority Review from the FDA for its Cancer Drug Zykadia as a Frontline Treatment for ALK-positive Non-Small Cell Lung Cancer Accesswire
07:17AM  CHMP Recommends EU Conditional Marketing Authorisation for Natpar® (Parathyroid Hormone) for Patients with Chronic Hypoparathyroidism PR Newswire
Feb-23-17 09:20AM  Biotech Movers: Shire Rises on Encouraging Angioedema Results
04:11AM  New England Journal of Medicine Publishes Phase 1b Results for Shire's Investigational Treatment for Hereditary Angioedema, a Rare Genetic Disease PR Newswire
02:00AM  Shire Launches 'Rare Count' Campaign to Personalize the Global Impact of Rare Diseases PR Newswire
Feb-22-17 04:56PM  SHIRE PLC Files SEC form 10-K, Annual Report
03:13PM  Momenta Tops Q4 Earnings, Shares Down on Warning Letter
11:55AM  Shire Plc :SHPG-US: Earnings Analysis: 2016 By the Numbers : February 22, 2017
11:05AM  Momenta 4Q Net 60 Cents a Share at Investopedia
Feb-21-17 02:01PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
09:27AM  Shire Plc :SHPG-US: Earnings Analysis: Q4, 2016 By the Numbers : February 21, 2017
Feb-20-17 09:57AM  3 Stocks to Invest in Big Pharma at Motley Fool
Feb-17-17 02:04PM  Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View
01:50PM  Shire PLC 4Q Earnings, Revenue Beat Street at Investopedia
01:08PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Feb-16-17 04:28PM  Drugmaker Shire Tops Q4 Views; Stock Pops To Six-Week High
08:14AM  Shire beats Street 4Q forecasts
07:52AM  Shire Reports Full Year 2016 Results With Record Revenue; Positioned for Continued Strong Growth Driven by Best-in-class Rare Disease Pipeline PR Newswire
07:25AM  Shire Beats Full-Year Earnings Estimates, Sees Robust 2017 Growth
Feb-15-17 04:24PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
12:49PM  Amicus Therapeutics Updates Migalastat Drug at Investopedia
Feb-14-17 07:30AM  Shire to Highlight Advancements in Rare Genetic Diseases PR Newswire
Feb-08-17 10:04AM  Shire ViroPharma Sued By FTC Over Sham FDA Filings at Investopedia
Feb-07-17 04:05PM  FTC says Shire unit used illegal tactics to block generic competition at bizjournals.com
03:42PM  Shire Responds to U.S. Federal Trade Commission Civil Action PR Newswire
10:45AM  Hemophilia Drug Market Competitive Ramps Up at Investopedia
Feb-02-17 10:40AM  5 Drugmakers Battle Over the $10 Billion Hemophilia Market at Motley Fool
Feb-01-17 03:49PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
01:39PM  New Data From Shire Aim to Help Close the Diagnosis and Treatment Gap for People With Hemophilia PR Newswire
Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various products for the treatment of attention deficit hyperactivity disorder (ADHD), including VYVANSE/VENVANSE, a pro-drug stimulant; ELVANSE/TYVENSE; INTUNIV, an alpha-2A receptor agonist; EQUASYM, a methylphenidate hydrochloride; and ADDERALL XR, an extended release treatment for ADHD. The company also provides PENTASA and LIALDA/MEZAVANT for ulcerative colitis treatment; and RESOLOR, a 5-HT4 receptor agonist for oral symptomatic treatment of chronic constipation in women. In addition, it offers FOSRENOL, a phosphate binder for use in end-stage renal disease receiving dialysis; and XAGRID for the reduction of elevated platelet counts in at-risk essential thrombocythemia patients, as well as for the treatment of thrombocythemia. Further, the company provides REPLAGAL for the treatment of Fabry disease; ELAPRASE for the treatment of hunter syndrome; VPRIV for the treatment of type 1 Gaucher disease; and FIRAZYR for the symptomatic treatment of acute attacks of hereditary angioedema. Additionally, it offers FOSRENOL for the treatment of hyperphosphatemia in end stage renal disease; XAGRID for the reduction of elevated platelet counts; and CINRYZE, a C1 esterase inhibitor therapy for routine prophylaxis against hereditary angioedema. The company also licenses its patented antiviral products for human immunodeficiency virus and hepatitis B virus. Shire plc markets its products directly to government hospitals, clinics, pharmacies, and other agencies; and through wholesalers and distributors. The company sells its products in North America, the United Kingdom, the Republic of Ireland, and internationally. Shire plc has research collaboration with Santaris Pharma A/S. The company was founded in 1986 and is headquartered in Dublin, Ireland.
DAL Delta Air Lines, Inc. daily Stock Chart
DAL [NYSE]
Delta Air Lines, Inc.